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MR-based treatment planning for proton therapy
Magnetic resonance imaging for image guidance of proton therapy could greatly reduce
dosimetric uncertainties during treatment, as uncertainties due to set-up or anatomical
changes can be detected and corrected for. For dose calculation, however, MR images
lack information on the stopping power of the tissue. The use of synthetic computed
tomography (CT) images derived from MR images was thus investigated using the example
of prostate cancer in this thesis.
First, the impact of bulk density (BD) overwrites in the planning CT for small (< 5) sets
of tissue classes was investigated. For the modified CT image with BD values for five
tissues, sufficient dosimetric agreement (mean gamma pass rates (GPRs) above 98.5 % for
the PTV) and mean absolute range difference below 1.8 mm were observed.
The same set of tissue classes was subsequently identified in the rigidly registered MR
image and overwritten with the same BD values as before. The mean GPR decreased
to 95.2 %, and the absolute range difference increased to 4.0 mm. The observed differ-
ences are unacceptable and emphasize the necessity of MR guidance for proton therapy of
prostate cancer.
Using a deformably registered MR image to overcome the anatomical differences be-
tween the CT and the MR, the dosimetric agreement was found clinically acceptable
for most cases (mean GPR = 97.6 %), and the mean absolute range difference decreased
to 2.7 mm.
The workflow implemented in this thesis allows fast and robust generation of synthetic
CT images for proton therapy. The presented conversion technique is compatible with
different MR scanners and can be extended to different anatomical sites with little extra
effort. While the full potential of MR images has not yet been tapped, synthetic CT
images are a useful tool for MR-guided proton therapy.

MR-basierte Bestrahlungsplanung in der Protonentherapie
Magnetresonanz (MR)-Bildgebung hat großes Potential, Unsicherheiten in der Protonen-
therapie zu reduzieren. Dazu za¨hlen Positionierungsunsicherheiten und anatomische Ver-
a¨nderungen im Patienten, die durch das MR Bild detektiert und korrigiert werden ko¨nnten.
Dem MR Bild fehlt jedoch eine entscheidende Information fu¨r die Dosisberechnung: das
Bremsvermo¨gen des Gewebes. Daher wird in dieser Arbeit die Erstellung und Anwendung
von sogenannten synthetischen Computertomographie (CT)-Bildern am Beispiel von Pro-
statakrebs untersucht.
Im ersten Schritt wurde eine geringe Anzahl (< 5) an Gewebeklassen im Planungs-CT
mit entsprechenden Gruppendichte-Werten u¨berschrieben. Das modifizierte CT-Bild mit
genau fu¨nf Gewebeklassen zeigte ausreichende dosimetrische U¨bereinstimmung mit dem
Planungs-CT (die mittlere Quote der Voxel mit akzeptabler Abweichung gema¨ß Gamma-
Analyse, vom Englischen ”Gamma Pass Rate (GPR)”, lag u¨ber 98.5 % fu¨r das PTV) und
der mittlere, absolute Reichweitenunterschied lag bei maximal 1.8 mm.
Anschließend wurden die gleichen fu¨nf Gewebeklassen aus dem rigide registrierten MR-Bild
klassifiziert und mit den entsprechenden Gruppendichte-Werten u¨berschrieben. Die mitt-
lere GPR sank auf 95.2 % und die mittleren, absoluten Reichweitenunterschiede stiegen
auf 4.0 mm. Diese Unterschiede zum Planungs-CT sind inakzeptabel und unterstreichen
die Notwendigkeit fu¨r MR-gefu¨hrte Protonentherapie bei Prostatakrebs.
Da große anatomische Vera¨nderungen zwischen den CT- und den entsprechenden MR-
Bilderm zu beobachten waren, wurden im letzten Schritt synthetische CT Bildern aus
deformierbar registrierten MR Bildern erstellt. In den meisten Fa¨llen waren die Bestrah-
lungspla¨ne dieser synthetischen CTs klinisch akzeptabel (mittlere GPR = 97.6 %), gleich-
zeitig sanken die mittleren, absoluten Reichweitenunterschiede auf 2.7 mm.
Der hier implementierte Ablauf ermo¨glicht die schnelle und robuste Erzeugung von synthe-
tischen CT Bildern und deren Analyse im Vergleich mit dem Planungs-CT. Die pra¨sentierte
Methode ist kompatibel mit unterschiedlichen MR-Scannern und kann mit wenig Mehr-
aufwand auf weitere Ko¨rperregionen erweitert werden. Das Potential der MR-gefu¨hrten
Protonentherapie ist noch nicht vollsta¨ndig ausgescho¨pft, jedoch sind synthetische CT-
Bilder ein wichtiger Schritt und ein nu¨tzliches Werkzeug auf dem Weg dahin.
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1. Introduction
Radiotherapy is one of the main therapeutic interventions in cancer therapy: esti-
mated 50% of all cancer patients would beneﬁt from it (Borras et al., 2015). Al-
though radiotherapy with protons is less available compared to conventional photon
therapy, the stopping power of charged particles in matter can be beneﬁcial for
treatment of immobile and localized tumours. Protons deposit most of their energy,
meaning they cause most cell damage, at the end of their range (Wilson, 1946),
the so-called “Bragg peak”. Therefore less beam angles are necessary to cover the
target, which better spares healthy tissue. To place the Bragg peak at the correct
position for therapy, knowledge of the energy absorption properties (dominated by
the electron density) of the tissue in the beam path is necessary. For this reason,
computed tomography (CT) images, which measure the attenuation of ionizing x-ray
radiation, provide the current gold standard for estimating of the electron density
with highest geometrical accuracy.
To treat less static tumours, repeated or even online imaging is desirable. This
motivates the use of magnetic resonance (MR) images for treatment planning, while
additionally sparing the dose burden of CT imaging. Up-to-date MR images could
be used for dose recalculation from the original treatment plan to detect a possible
need for action, or treatment planning itself. However, electron density cannot
be assessed by means of MR, which measures the magnetization of protons in the
tissue in the presence of magnetic ﬁelds. The diﬀerence between a CT and an
MR image is visualized in ﬁgure 1.1. A detailed description of the two imaging
modalities can be found in section 2. In proton therapy, the need for up-to-date
or live information on electron density distribution is especially crucial, due to the
steep dose gradients of the proton beams: changes in electron density caused by
anatomical or geometrical changes in the beam path can lead to severe changes in
the position of the Bragg peak, leading to underdosage of the tumour or overdosage
of healthy tissue. Examples for such changes in anatomy are organ motion during the
treatment, daily positioning errors, tumour shrinkage or patient weight loss in the
course of the treatment (Lomax, 2008). While MR imaging is superior in detecting
these changes, the electron density as the basis for dose calculation, however, has to
be included in the image by other means.
One solution for including electron density information into an MR image is the
generation of so-called “synthetic computed tomography (sCT)” images. SCTs have
been investigated in many studies during the last years (comprehensive reviews have
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Figure 1.1.: Left: Axial slice of a CT scan from a pelvic cancer patient. Right:
Corresponding slice to the CT slice of a T2 weighted MR scan.
been published by Johnstone et al. (2017) and Edmund and Nyholm (2017)), mostly
for photon therapy applications. For conventional radiotherapy of pelvic cancer,
commercial products (Tyagi et al., 2017; Siversson et al., 2015) are available on the
market, as well as integrated into combined MR imaging and radiotherapy devices
(so-called ”MR-linacs”). For proton therapy, less literature is available. Approaches
with diﬀerent levels of complexity have been applied: from simple bulk density (BD)
overwrite techniques (Maspero et al., 2017), over the dual model by Koivula et al.
(2016), to more complex machine learning techniques (Rank et al., 2013; Edmund
et al., 2014; Pileggi et al., 2018; Spadea et al., 2019). More details on the available
techniques can be found in section 3.2.
The aim of this thesis was the generation of sCT images for proton therapy of
prostate cancer. Prostate cancer could beneﬁt from MR-guidance, as it is prone to
anatomical changes. For the purpose of sCT generation, in a ﬁrst step the required
granularity of the image, i.e. the number of required BD overwrite values, was in-
vestigated. This was done on the original planning computed tomography (pCT)
image to avoid the inﬂuence of the choice of the MR sequence, artefacts therein,
or the conversion technique. In the second step, the respective BD classes were
segmented from an MR image to create MR-based sCT images. The MR image
was corrected for common types of artefacts to investigate their impact. The idea
behind this approach is described in detail in section 3.3. The quality of the sCT
images was analysed in comparison to the pCT based on proton range diﬀerences
and dosimetric changes. For more details on the image processing and the analysis
the reader is referred to section 4.
2. Physics background
In this section, the most important principles for magnetic resonance (MR) imaging,
computed tomography (CT) imaging and radiotherapy will be explained, which are
strongly interlinked nowadays within radiotherapy. CT and MR imaging provide
anatomical information about the patient, allowing to identify the tumour volume
and critical structures in close proximity to the tumour. In addition, CT provides
information necessary for the calculation of energy loss of ionizing radiation in the
body. Knowledge on the energy loss is essential for accurately delivering a clinical
amount of dose to the tumour, while sparing healthy tissue as much as possible.
Radiotherapy using photons is the most common method, however proton ther-
apy becomes more and more available all over the world. Photons and protons
(as charged particles) diﬀer strongly in their physical properties and interaction
behaviour when travelling through matter, determining their advantages and disad-
vantages.
2.1. Magnetic Resonance
When protons (spin 1
2
) are placed within a constant magnetic ﬁeld ~B0, they will
acquire two spin states |↑〉 and |↓〉, named spin up (”parallel”) and spin down (”anti-
parallel”). The ratio between parallel and anti-parallel spins is given by the Boltz-
mann distribution, which describes the excess of parallel spins over anti-parallel
spins in dependence of the temperature. At body temperature (T = 310K) and
| ~B0| = 1.5T the excess is in the order of 10−6. Considering the huge number of pro-
tons in the human body, this excess creates a detectable macroscopic magnetization
~M0 with magnitude M0. Conventionally, the direction of ~B0 is referred to as the
z-direction, giving M0 =Mz.
To excite a nuclear magnetic resonance, a time-dependent radio-frequency (RF)
pulse is applied irradiating at the Larmor frequency ωRF = ω0 = γ| ~B0|, with γ being
the gyromagnetic ratio. The gyromagnetic ratio is a characteristic property of a
nuclei with spin. For protons, γ ≈ 26.75 radT−1s−1, leading to a resonance frequency
ω0 ≈ 267.51 MHz or ν0 ≈ 42.58 MHz at a magnetic ﬁeld strength of 1 T. The RF
ﬁeld has a polarization such that it acts as a magnetic ﬁeld ~B1 perpendicular to
~B0. The transmitted pulses are generated by dedicated coils (RF antenna systems)
mounted in the bore of the magnet. The magnetization is composed of a component
3
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parallel and a component perpendicular to ~B0 called Mz and Mxy, respectively. An
RF pulse with a duration such that ~M0 is ﬂipped by 90° is denoted a 90°- or
π
2
-
pulse. Analogously, any other angle α can be achieved depending on the length of
the pulse. The Mxy magnetization precesses around B0 with the Larmor frequency
and induces a voltage in the RF coils, which is the source of the signal in MR. These
receiving coils are generally ﬂexible coils mounted close to the patient for better
signal detection.
After RF excitation, relaxation of the transversal (Mxy → 0) and longitudinal
(Mz →M0) magnetization occurs. It is caused by dipole-dipole interactions between
the spins leading to ﬂuctuations in the local magnetic ﬁelds and thus changing the
Larmor frequency locally (spin-spin relaxation). Also interactions with the environ-
ment by thermal coupling to the surrounding material (spin-lattice relaxation) lead
to a relaxation. The recovery of the initial state of magnetization is described by
the Bloch equations (Bloch, 1946). The spin lattice relaxation induces the recovery
of the initial state in z-direction:
Mz(t) =Mz,t=0 · e−t/T1 +M0 · (1− e−t/T1), (2.1)
with t = 0 being the end of the RF pulse, whereas the spin-spin relaxation causes
a de-phasing of the individual spin packets, measured as a loss of magnetization in
the transversal plane:
Mxy(t) =Mxy,t=0 · e−iω0t · et/T2∗ . (2.2)
T1 and T2/T2∗ are the longitudinal and the transversal relaxation times, respec-
tively. The magnitude of T1 and T2 depends on the state of the probe: in solids,
T1 is very long (hours or days), whereas T2 is very short (milliseconds). In soft
human tissue, T1 is in the order of seconds, and T2 is in the order of 100 ms. Thus,
diﬀerent materials can be distinguished based on their relaxation time diﬀerences.
T1 and T2 are highly dependent on the tissue, which explains why the soft tissue
contrast in MR imaging is superior to other imaging methods.
In reality, inhomogeneities of the magnetic ﬁeld e.g. due to technical limitations
or local susceptibility diﬀerences, will accelerate the de-phasing of spin packets and
thus the decay of Mxy. The overall relaxation time denoted T2
∗ is shorter than
without these inﬂuences (T2∗ ≤ T2). A relaxation with time constant T2∗ directly
following the excitation RF pulse is called a free induction decay.
2.1.1. The MR Experiment
To distinguish signals from diﬀerent points in the sample after excitation, additional
magnetic ﬁelds with well-deﬁned spatial dependence, so-called gradient ﬁelds ( ~G),
are superimposed onto ~B0 such that ~B = ~B(~x). This changes the Larmor frequency
to be a function of space:
ω0 = ω0(~x). (2.3)
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The gradient ﬁelds are then used during the MR experiment in the excitation phase
for spatially selective excitation, and in the relaxation phase for frequency encoding
and phase encoding. Frequency encoding changes the frequency of the magneti-
zation depending on the position, phase encoding will change the phase angle of
the magnetization depending on the position. Selective excitation is used for signal
diﬀerentiation for example in z-direction, then frequency and phase encoding are
used for the x-y-plane. In addition, RF pulses of 180° can be used to refocus the
decaying signal (caused by the de-phasing of the spins). This way, a second free
induction decay (a ”spin echo”) can be measured at TE (echo time). A succession
of excitation RF pulses, imaging gradients, and refocussing RF pulses is called an
MR imaging sequence.
During acquisition of an MR image, the signal intensity at speciﬁc points in time
along the exponential increase/decay is measured. These points are deﬁned by
TE and the repetition time TR. Adapting those, focus can be put on diﬀerences
between tissues in T1, T2, proton density (PD), or combinations of the three. It
should however be noted that a PD weighting is present in all images. Depending on
which relaxation time is emphasized, the MR sequences are labelled ”T1-weighted”,
”T2-weighted” or ”PD-weighted”, with the former two being the standard sequences
used in the clinics.
The MR images used in this study are mainly T1- and T2-weighted spin echo se-
quences. Spin echo sequences have been developed in the early years of MR imaging
and are still widely used. The basic pulse sequence is [90° - TE/2 - 180° - TE/2 - AQ
- TD] with AQ being the signal acquisition and TD = TR − TE the delay time until
the next pulse sequence starts. The signal intensity SSE of a voxel is given by
SSE = PD · [1− e−TR/T1] · e−TE/T2. (2.4)
T1-weighting can be achieved with TR = T1 and TE << T2, T2-weighting with
TR >> T1 and TE = T2.
Gradients for slice selection and phase and frequency encoding are applied sequen-
tially, the latter two are varied N, respectively M times, to ﬁll a plane with sig-
nal intensities in the frequency domain. Generally, N is equal to M, to obtain
quadratic pixels in the image and a quadratic image. To obtain the MR image, a
two-dimensional (2D) Fourier transform is applied. The resulting image also has a
resolution of NxM pixels. Thus, in this simple form, the basic sequence has to be
repeated NxMxP times, to achieve a three-dimensional (3D) image with P slices.
Fast spin echo sequences use multiple echoes instead of just one echo with varying
phase encoding to decrease acquisition time. An example of the gradient sequence
for a fast spin echo sequence in shown in ﬁgure 2.1.
Examples of T1- and T2-weighted MR images acquired with fast spin echo sequences
are shown in ﬁgure 2.2.
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Figure 2.1.: Gradient sequence for a fast spin echo sequence with four echos, i.e.
four 180°-pulses. Figure adapted from Weishaupt et al. (2014)
.
(a) T1-weighted MR image (TE = 7.2ms
and TR = 600ms).
(b) T2-weighted MR image (TE = 97ms
and TR = 6000ms).
Figure 2.2.: Two images acquired with fast spin echo sequences showing two diﬀerent
contrasts depending on the echo time TE and repetition time TR.
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2.1.2. Artefacts in MR
MR imaging is a complex process, both physically and technically, giving rise to
many artefacts. Here, artefacts relevant for dose calculation based on MR images
are brieﬂy explained.
1. The air/bone ambiguity
In T2-weighted MR sequences, both bone and gas, for example air, have very
low signal intensity. In air, the reason is the low density of protons that con-
tribute to the macroscopic magnetization and thus the signal. In bone, enough
protons are available, but as a solid material, the decay of the transversal mag-
netization is too fast to detect the signal of an echo with standard echo times.
Therefore, sequences with ulta short echo time (UTE) or zero echo time (ZTE)
(which simply measure the free induction decay) have been developed. Bone
will then have a small signal, whereas air is still void.
2. Image distortion
The localisation of signal in MR is done via gradient ﬁelds overlaid on a ho-
mogeneous, static ﬁeld ~B0. If either ~B0 is not perfectly homogeneous, or the
gradient ﬁelds are not exactly linear, the detected signal will appear to orig-
inate from a slightly diﬀerent location than expected. In the image, this can
be seen as distortions. Also the patient itself can aﬀect ~B0 via susceptibility
eﬀects, and thus introduce inhomogeneities in the magnetic ﬁelds, leading to
distortions.
3. Bias ﬁeld
A bias ﬁeld is a slowly varying, additive ﬁeld, which may appear to the observer
as an uneven illumination of the image. In ﬁgure 2.2, it is clear to see at the
subcutaneous fat in both images, which from a physical point of view should
have the same grey value independent of location in the image. However, some
areas are brighter than others. This eﬀect is caused by inhomogeneities in
the ~B1 ﬁeld and inhomogeneity of the sensitivity of the RF coil that receives
the MR signal. Generally, regions close to the coil appear brighter (higher
sensitivity of the coil).
2.2. Computed Tomography
CT imaging refers to a 3D image of a patient based on the transmission of x-rays
through the body. During transmission, the photons interact with the atoms in the
body, changing the intensity of the in-going photon beam according to Lambert-
Beer’s law of absorption:
T (x,Eγ, Z) =
I(x)
I(0)
= e−µ(Eγ ,Z)·x (2.5)
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with T the transmission, I the beam intensity, x the traversed path, Eγ the energy
of the photons, Z the eﬀective atomic charge number of the traversed material, and
µ the linear absorption coeﬃcient of the material.
Three physical eﬀects contribute to the absorption coeﬃcient depending on the
beam’s energy and the charge number: the photoelectric eﬀect (PE), Compton
scattering (CS) and pair production (PP). The total energy of the incoming photon
in the PE is used to emit an electron from a target atom, which will deposit its energy
locally. The absorption coeﬃcient of the PE, µPE, is approximately proportional
to Z3/E3γ . Figure 2.3 illustrates that the PE dominates the absorption coeﬃcient
(here normalized to mass density) for photon energies below 30keV and is generally
only relevant below 100keV. Above that, CS is the most important eﬀect. CS is
the incoherent scattering of the photon at an electron, which will then be emitted
from the atom. From ﬁgure 2.3 it can also be seen that CS, especially in the energy
regime relevant for CT imaging (30-150keV), is almost independent from the photon
energy. It is also hardly dependent on Z, but shows proportionality to the electron
density ρe of the absorbing material. PP of an electron-positron pair in the strong
electromagnetic ﬁeld of an atomic nuclei can only happen at photon energies above a
threshold of 1.022MeV. The positron will annihilate with an electron of the material
and thereby emit two photons with E = 0.511MeV. Only above 20MeV, the impact
of PP is dominant, as can be seen in ﬁgure 2.3. µPP is proportional to Z and
increases with energy. PP is not relevant for imaging, because the photon energies
are well below the threshold.
Equation 2.5 assumes a beam passing through a homogeneous material. The human
body however is very heterogeneous in its composition (Z and ρe), and thus are the
absorption coeﬃcients. This changes equation 2.5 as follows:
T (x,Eγ, Z) = e
−
∫
x
0
µ(Eγ ,Z,x)dx. (2.6)
In CT imaging, absorption proﬁles through the body are acquired from diﬀerent
directions (covering at least 180°), as shown in ﬁgure 2.4 (left) for the ﬁrst CT
scanner designs. After scanning many parallel lines to create one absorption proﬁle,
the x-ray tube and the scanner are rotated and the measurement starts again. At
this point, the absorption coeﬃcient of each voxel in the ﬁeld-of-view (FOV) is still
unknown, but contributes to each absorption line that passes the voxel. With that,
an equation system is created, whose solution gives the CT image. Nowadays, the
most common solutions are analytical and iterative reconstruction algorithms.
This implementation for measuring absorption lines is very slow, which is why nowa-
days all clinical scanners consist of an x-ray tube creating a fan-shaped beam (cf.
ﬁgure 2.4 (right)), mounted on a gantry ring. On the gantry, a curved, pixelated
solid-state detector in mounted opposite of the x-ray tube. This set-up is called
fan-beam geometry. Thus, many absorption lines are measures simultaneously in-
stead of successively. To scan a slice, the gantry rotates around the patient. Modern
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Figure 2.3.: Absorption coeﬃcients of water normalized by the mass density over
the photon energy for the photoelectric eﬀect, Compton scattering, pair
production and the total sum of them. The grey area indicates the
energy range relevant for CT imaging (30keV - 150 keV). Data taken
from the NIST XCOM Photon Cross Section Database (Berger et al.)
scanners also have several rows of detectors to measure more than just one slice at a
time. For faster volume acquisition, the gantry rotation is overlaid to a movement in
z-direction (deﬁned as the cranial-caudal direction), i.e. a spiral movement, instead
of acquiring one slice at a time.
In a CT image, the grey value of a voxel represents the spatial distribution of ab-
sorption coeﬃcients of the material within the voxel. To make images from diﬀerent
scanners which may have diﬀerent energy spectra comparable, a normalization of the
absorption coeﬃcients to water is introduced, called the CT scale given in Hounsﬁeld
unit (HU):
H(µ) =
µ− µw
µw
· 1000 [HU]. (2.7)
µ is the absorption coeﬃcient of the voxel, and µw the absorption coeﬃcient of
water. The scale ranges from -1000 HU for vacuum to 0 for water and continues
theoretically to inﬁnity. In practice, it ranges from -1024 HU for vacuum to 3071 HU
for high absorption material, as it can be stored in binary system with only 12 digits.
Soft tissues range between -120 HU for fat and 300 HU for muscles and organs. Bony
tissue ranges from 300 to 1900 HU. Foreign materials, e.g. metals in prosthetics,
are at the upper end of the scale and clipped to 3071 HU.
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Figure 2.4.: Schematics of CT scanning methods. On the left, the ﬁrst generation of
scanners with a pencil-beam scanning parallel lines before rotating to a
diﬀerent angle is shown. On the right, an x-ray tube which generates
a so-called fan-beam is shown, which is detected by a curved, pixelated
detector. Image source: Bushberg et al. (2012).
One disadvantages of CT imaging are the poor image contrast within soft tissues,
which are for example necessary in oncology to locate tumours and metastases.
Also the dose burden to the patient from the x-rays might hinder more frequent
use of CT imaging. On the other hand, the image contrast between soft tissue and
bone is very high, and 3D images with high spatial accuracy can be acquired much
faster than with other imaging modalities. The spacial accuracy is ensured by the
application of projections, instead of using a mediating property for voxel locations
as the magnetic ﬁeld in the case of MR imaging. The most important property of
CT imaging in the context of oncology however is its direct dependency on electron
density and atomic number of the tissue, which are the relevant parameters for dose
calculation in radiotherapy.
2.3. Radiotherapy
Radiotherapy is one of the main pillars of cancer therapy, together with surgery and
chemotherapy. Its principle is to deliver a high amount of energy to the tumour
cells, which will ultimately kill the cells, while trying to spare healthy tissue. The
commonly used quantity to describe this delivered energy is dose, which is deﬁned
as the mean absorbed energy per mass:
D =
dE
dm
[J kg−1 = Gy] (2.8)
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When physicians decide to apply radiotherapy for cancer therapy of a patient, several
steps have to be taken before irradiating the tumour. First, a computer model of the
patient is created. This model is based on the CT image of the patient in treatment
position, which has high spatial accuracy and contains information on the energy
absorption properties of the tissue. MR images or functional images like positron
emission tomography (PET) can add information on soft tissue and tumour location,
which might not be available in the CT. These images have to be registered to the
CT for spatial correlation. In a second step, the gross tumour volume (GTV) and
organs at risk (OARs), i.e. healthy organs that could suﬀer irreparable damage from
radiation, are contoured in the images. The GTV will be extended to include tumour
spread at the cell-level to form a clinical target volume (CTV). To include planning
and treatment uncertainties, the CTV is further extended to form a planning target
volume (PTV). The additional volume added by the PTV acts as a safety margin.
Afterwards, the dose that should be delivered to the PTV is prescribed and dose
constraints for OARs are assigned. Dose constraints are well-deﬁned thresholds,
that should not be exceeded. For example: the maximum dose considering all
voxels in the urinary bladder should not exceed 65 Gy (Marks et al., 2010). Dose
constraints are generally based on dose-volume histograms (explained in detail in
section 4.7). Prescribed dose and dose constraints are important input parameters
for the calculation of the treatment plan in the next step. Nowadays, only limited
parameters like treatment particle, number of beam angles, tumour volume, etc.,
are set beforehand. Other parameters, like the weighting of individual pencil-beams
within one beam, are optimized in an iterative process called inverse planning. Only
after all requirements are met, i.e. the tumour receives the prescribed dose and all
OARs are spared according to the constraints, the treatment is delivered to the
patient.
Another method to spare healthy tissue is to deliver the treatment in a fractionated
fashion. Instead of delivering all dose in one session, it is split into smaller doses
which are delivered successively on diﬀerent days. This leads to a higher tumour
control while lowering the risk of permanent damage in healthy tissue. Typically, a
treatment is delivered in 20 - 30 fractions with 1.8 - 2 Gy each, but other schemes
are possible depending on the indication.
2.3.1. Intensity modulated radiotherapy
The most common type of radiotherapy is using high energetic photons (approxi-
mately between 1 and 10 MeV), sometimes referred to as ”conventional radiother-
apy”. Simple x-ray tubes are not suﬃcient any more to produce such high energy
photons. Instead, electrons are accelerated using a linear accelerator (linac) to reach
respective energies that create ultra-hard x-rays when hitting a metal target. To
describe the beam’s energy, the accelerating voltage of the electrons is given in MV
12 Chapter 2 Physics background
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
0
0.2
0.4
0.6
0.8
1
1.2
depth in water [cm]
d
os
e
[a
.u
.]
Depth Dose Curves
target
SOBP
128MeV protons
6MV photons
Figure 2.5.: Depth dose curves produced by a 6MV photon beam (orange), by a
128MeV proton beam (blue), and by a spread-out Bragg peak (SOBP)
(black) covering a target (grey area).
rather than the energy of a monoenergetic beam, because the output of the linac
is a spectrum of energies. The resulting radiation is collimated to form a beam.
The physics of the photons in the beam hitting matter is similar to the physics in
CT imaging, however the higher energies have the consequence that the absorption
is dominated by CS and, above 1.022 MeV, also PP, whereas the PE can be ne-
glected (cf. ﬁgure 2.3). The energy deposition in the patient mostly occurs due
to the secondary electrons from the CS in Coulomb interactions with electrons of
the body. Thus, a build up eﬀect at the beam’s entrance into the patient can be
observed, which reduces the dose to the skin. After the build-up, secondary electron
equilibrium can be assumed, in which the dose deposition decreases exponentially
following Lambert-Beer’s law while traversing matter, as seen for the orange curve
for a 6 MV photon beam in ﬁgure 2.5.
For dose calculation, a fast analytical approach, which is widely used, is the pencil-
beam algorithm (Bortfeld et al., 1993). It calculates the dose at a point (xP , yP , zrad)
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deposited by a pencil-beam with the central axis at (x, y) as
D(xP , yP , zrad) =
∫∫ ∞
−∞
Φ(x, y)F (x, y)K(x− xP , y − yP , zrad)dxdy. (2.9)
Φ(x, y) is the primary ﬂuence of the beam, F (x, y) the transmission factor tran-
scribing the intensity-modulation of the beam (i.e. a collimation of the beam to the
projected shape of the tumour) and K is 3D kernel, which describes the shape of
the beam laterally and in depth. zrad is the radiological depth (rD) that determines
the absorbed dose in a heterogeneous material (also compare equation 2.6):
zrad =
∫ P
0
µ(l, Eγ)dl. (2.10)
The absorption information µ is derived from the CT image using a Hounsﬁeld look-
up table (HLUT) (for more details see below), which has discrete voxel information.
Thus, the rD is not an integral but a sum over the products of the length of the
path within voxel i, li, and the absorption coeﬃcient in this voxel, µi:
zrad =
N∑
i=0
liµi. (2.11)
To characterize the kernel, the dose calculation algorithm depends on detailed know-
ledge of the pencil-beams, which are measured or simulated in water in advance.
For this reason, it is convenient to make all calculations ”relative to water”. The rD
relative to water is
ẑrad =
zrad
zrad,w
=
N∑
i=0
li
µi
µw
=
N∑
i=0
li
ρe,i
ρe,w
=
N∑
i=0
liρ̂e,i. (2.12)
ρ̂e,i is the relative electron density (rED), which is the dominant tissue property to
aﬀect the absorption of MeV-photons. The calculation of ẑrad for all target points
in the tumour volume is called ray casting.
Thus, it is assumed that spatial rED information of the patient is available. But the
energy dependence of the absorption behaviour of tissue (cf. ﬁgure 2.3) implies that
the CT numbers can not directly be used for dose calculation. Instead, the CT image
is translated to a rED image using the so-called HLUT. The HLUT is a piece-wise
linear function and determined based on measurements of known materials and/or
tissue surrogates.
With a pencil-beam algorithm, a calculation of dose is possible given its energy,
ﬂuence and transmission factor. This is called forward calculation. To reach a pre-
scribed dose in the tumour while sparing healthy tissue, several beams are irradiated
from diﬀerent angles, overlapping in the target (as illustrated in ﬁgure 2.6 (left)).
For complex geometries, for example when an OAR lies in close proximity to the
tumour, it is often diﬃcult to spare the OARs appropriately. In this case, the inten-
sity across the beam can be adapted, which is advantageous for example for concave
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Figure 2.6.: Comparison between non-modulated (left) and intensity-modulated ra-
diotherapy (IMRT, right). In IMRTthe intensity of the primary beam Φ
is adapted across the beam to deliver lower doses to OARs, as the green
structure in the example shown here. The high dose area delivered by
the two methods is indicated by the yellow line each. Adapted from:
Schlegel et al. (2018).
tumour shapes around an OAR. This technique is referred to as intensity-modulated
radiotherapy (IMRT). The diﬀerence between the non-modulated radiotherapy and
IMRT is demonstrated in ﬁgure 2.6: on the left, the OAR in green receives the same
dose as the tumour in red indicated by the yellow line for the high dose region. On
the right, the intensity of the beam is reduced where the beam passes through the
OAR and increased where the beam only passes through tumour.
The variation of the intensity within one beam increases the degrees of freedom for
the plan parameters. It is not feasible to manually set all parameters and do a for-
ward calculation. Thus, only the number of beams and their angles are speciﬁed by
experienced physicians. The shape of the beams is deﬁned by the projected contour
of the tumour. This leaves only the intensity modulation across the beams to be
optimized by computational methods before the dose can be calculated. Therefore,
this approach is called ”inverse treatment planning”. The optimization is based on a
linear relationship between the dose in a voxel i and the intensity of a partial ﬂuence
element of the beam, or pencil-beam, called ”bixel” j:
di =
∑
j
Dijwj, (2.13)
with Dij being the so-called dose inﬂuence matrix. The intensity vector wj, which
describes the intensity modulation of a beam, can be optimized iteratively based on
objective functions F , that penalize for example a dose diﬀerence from the prescribed
dose in the tumour, or exceeding of a dose constraint in an OAR. The solution of
the inverse problem is the minimization of the objective function:
w∗ = argmin
w≥0
F (w).
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2.3.2. Intensity modulated proton therapy
Proton therapy, another type of radiotherapy, is getting more and more available
worldwide. Protons are charged particles, that interact via electromagnetic and
hadronic forces with matter. The mean energy loss dE during these interactions on
the path dx is described by the stopping power:
S =
dE
dx
. (2.14)
Hadronic forces, i.e. interactions with atomic nuclei of the traversed matter, lead
to fragmentations of the nuclei. Also elastic interactions with atomic nuclei occur,
however the energy loss is negligible in these interactions, i.e. the stopping power
Snuc does not contribute signiﬁcantly to the overall stopping of the protons. The
most important interaction is the Coulomb interaction with electrons also known as
the collision stopping power Scol, which slows down the protons continuously. This
interaction is dominating the dose:
D ∼ Scol
ρ
· Φ (2.15)
with Φ the primary ﬂuence and ρ the mass density. The fraction Scol/ρ is described
by the Bethe formula (Bethe, 1930):
Scol
ρ
= k · ZA
AA
· 1
β2
· [1
2
ln(
2mec
2γ2β2
I
)− β2]. (2.16)
k is a constant factor (≈ 0.307MeV · cm2/g), ZA the charge number, AA the atomic
number of the traversed matter, β = v/c the velocity, me the mass of an electron, c
the speed of light, γ is deﬁned as 1/
√
1− β2, and I is the mean excitation energy
of the traversed material. Correction factors for high and low energies are neglected
here. In analogy to the rED, the relative stopping power to water, also called
stopping power ratio (SPR), is introduced as
SPR =
Smatter
Swater
. (2.17)
The range of the particle entering matter with energy E under the continuous slowing
down approximation is deﬁned as
R(E) =
1
ρ
∫ E
0
1
S(E ′)dE′
. (2.18)
A proton with energy 220MeV for example has a range of approximately 30 cm in
water.
The characteristic stopping behaviour of charged particles (−dE/dx ∝ 1/β2) leads
to an advantageous dose deposition in the patient: low dose in the entrance channel
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and high dose in the so-called Bragg peak at the end of the particles range. Figure
2.5 shows a single Bragg peak produced by a 128 MeV proton beam (blue line).
To cover an extended tumour volume in depth (grey area in the ﬁgure), several
Bragg peaks from protons with diﬀerent energies are overlaid to form a spread-out
Bragg peak (SOBP), as shown as a black line in ﬁgure 2.5. To cover the tumour in
lateral directions, several pencil-beams are placed next to each other. The sum of
all pencil-beams from the same entrance direction is called a beam. The intensity,
i.e. the number of protons, can be varied between pencil-beams within a beam,
and the modulation of the intensity is likewise advantageous as in photon therapy
to spare OARs. This technique was therefore introduced as intensity-modulated
proton therapy (IMPT).
The fastest way to calculate the dose of a proton beam, similar to photon dose
calculation, is a pencil-beam algorithm (Hong et al., 1996). The description of a
pencil-beam is split into a lateral dose proﬁle and a depth dose curve:
d(~r) =
1
2πσ2
· e− (x−µx)
2
2σ2 · e− (y−µy)
2
2σ2 · Z(zrad), (2.19)
with µx and µy are the lateral beam position. From equation 2.19 it can be seen
that the lateral dose proﬁle can be described with a Gaussian function with beam
width σ. σ also has a dependency on zrad as a consequence of multiple Coulomb
scattering (MCS) and inelastic interactions, thus both σ and the depth dose curve
Z(zrad) are based on measurements in water. The rD is deﬁned in analogy to photon
therapy:
zrad =
N∑
i=0
liSPR. (2.20)
The process of the treatment planning is also comparable to IMRT. First, the CT
image is converted using a HLUT to SPR. The HLUT is generated via measurements
of CT numbers and SPR using known materials and/or tissue surrogates. As for
the photon HLUT, the proton HLUT is a piece-wise linear function.
Compared to photon therapy, less beams are suﬃcient to cover the target adequately
while sparing the healthy tissue suﬃciently. Typically, 2-3 beams are used in IMPT,
compared to 6-9 beams in IMRT. The reason in the inverse dose proﬁle of the proton
beam, as it was visualized for a SOBP in ﬁgure 2.5. Less beams ultimately also lead
to a lower total dose in healthy tissue, as the beams go through less volume.
When delivering the same physical dose to cells with photons and protons, the
fraction of surviving cells will be lower for proton therapy. The reason is the higher
eﬃciency of protons to cause lethal complex DNA breaks in the cells. For treatment
planning, this eﬀect is considered using the concept of relative biological eﬀectiveness
(RBE). RBE is deﬁned as the ratio of dose delivered via photons and dose delivered
via protons, leading to the same iso-eﬀect. For protons, a constant RBE of 1.1 is
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used for dose calculation. To distinguish whether a given dose is physical dose or
biologically eﬀective dose, it is reported as Gy or Gy(RBE), respectively.
Ray casting is performed to know the rD of each target point inside the tumour, and
the dose inﬂuence matrix is calculated. As the dose optimization has an additional
degree of freedom compared to photon therapy, namely the depth modulation using
proton beams with diﬀerent energies, the Dij matrix is much larger than in the
photon case, where the energy is ﬁxed. Dose prescriptions and constraints are
included in the objective functions F , which are iteratively minimized to ﬁnd the
optimal intensity vector wj.
2.3.3. Uncertainties in radiotherapy
The complexity of radiotherapy causes many sources of uncertainties. Describing
and explaining all uncertainties and their origin is beyond the scope of this the-
sis, thus only uncertainties relevant to the analysis performed during this work are
explained.
CT imaging oﬀers high spatial accuracy with absorption information. To overcome
its low tissue contrast, MR and if necessary also PET images are acquired and used
for delineation. Nevertheless, the delineation is done manually and introduces an
intra- and inter-observer variability. Fiorino et al. (1998b) performed a comparison
study with ﬁve trained radiotherapists, that contoured the prostate in CT images
of six patients. The intra- and inter-observer variability in prostate volume was up
to 9 % and 18 %, respectively. It can be expected that the variability decreases
when using MR images. These images, however, introduce further errors. Firstly,
the MR is prone to distortions. Even after distortion correction, the prostate vol-
ume can suﬀer from distortions up to 0.5 mm (Nyholm et al., 2009) Secondly, the
contours have to be propagated to the CT, on which further treatment planning is
conducted. This propagation is done via image registration, which introduces an
error of approximately 2 mm (Roberson et al., 2005).
Range uncertainty aﬀects both treatment modalities, however the impact in proton
therapy is more severe due to the steep dose gradients compared to photon ther-
apy. One source of range uncertainty is the applied HLUT, which cannot cover
non-tissue-like materials such as implants (Schaﬀner and Pedroni, 1998) or inter-
patient variations (Woodard and White, 1986). So far, also no real patient tissue
has been used to create HLUTs, which introduces the uncertainty of the surrogates
themselves. The reported uncertainty introduced solely by the HLUT is about 1 %
of proton range (Schaﬀner and Pedroni, 1998).
After treatment planning, the largest uncertainties are related to patient position-
ing and inter- and intra-fractional anatomical variations (Lomax, 2008). Correct
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positioning of the patient is essential for the accuracy of the irradiation, and mea-
sures, such as thermoplastic masks for head irradiations or special mattresses for
irradiations in the abdominal or pelvic region, are taken to make patient position-
ing reliable. Still, uncertainties of about 3 mm have been reported by Fiorino et al.
(1998a). Pre-treatment imaging, for example using x-ray imaging or cone-beam
CT (CBCT), can be used to detect and correct misalignment of the patient, and is
based on reference points such as ﬁducial markers or bony anatomy. Wu et al. (2001)
reported random and systematic isocentre position shifts of 2.2 mm and 1.4 mm,
respectively. This, however, does not reﬂect and correct intra- and inter-fractional
motion relative to the reference points. Intra- and inter-fractional motion can in-
clude heart beat, breathing, organ motion, weight loss or tumour shrinkage. For
prostate cancer for example, organ motion can be up to 10mm (Roeske et al., 1995),
not including other anatomical variations.
3. MR-based dose calculation
The following section explains the rationale behind dose calculation on magnetic
resonance (MR) images. Several methods that are currently available in the liter-
ature are explained brieﬂy detailing their advantages and disadvantages. The goal
of this thesis and the idea behind its implementation is described at the end of this
section.
3.1. Motivation
From a physical point of view, dose calculation on MR images for radiotherapy is
neither obvious nor reasonable: the properties of the tissue that are probed in the
MR are not related to the necessary properties needed for dose calculation (either
relative electron density (rED) or stopping power ratio (SPR)). Also, MR is prone
to artefacts such as distortions induced by magnetic ﬁeld inhomogeneities, patient-
induced inhomogeneities, or gradient non-linearities (Tanner et al., 2000), which can
only partially be accounted and corrected for. In comparison, the geometrical ﬁdelity
is very high in computed tomography (CT) imaging. An advantage of the MR is
that it provides images with superior soft tissue contrast (Austin-Seymour et al.,
1995) and is already used in the context of radiotherapy for volume delineations
(ICRU, 2010). These delineations, however, still have to be transferred to the CT
via image registration, which introduces an error to the resulting treatment plan
(Nyholm et al., 2009). MR-only treatment planning could avoid this registration
error and spare the eﬀort of imaging both CT and MR. Another advantage of MR
imaging is the absence of ionizing radiation, as compared to CT imaging with x-ray
radiation. The patient is not exposed to an additional dose burden due to imaging.
Besides, frequent imaging, which would potentiate the dose burden, is especially
important for tumours that shift inter- or intra-fractional. Examples for such shifts
can be organ motion or positional shifts of the patient on the treatment couch.
Imaging is also important in cases where the tumour is in close proximity to critical
organs at risk (OARs), where exact knowledge on position of the tumour relative to
the OAR is crucial for treatment outcome. For this reason, investigations on how
to make use of the MR image for dose calculation have already started around the
year 2000 (Khoo et al., 1997; Beavis et al., 1998; Lee et al., 2003; Chen et al., 2004)
and have increased steadily over the past years. The only investigated approach so
far is to generate so-called synthetic computed tomographies (sCTs) images from
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the MR image. Independent from the method used to generate sCT images, all
methods detect certain properties of the tissue in the MR image (e.g. grey value,
location of voxels, texture, etc.) and assign CT numbers to that tissue. An overview
over the most common approaches is given in the following section. A boost in MR
technology, such as new MR sequences, and an increase in computational power
have accelerated the use of MR imaging steadily over the past years.
3.2. Available Methods
The algorithms reported in the literature to generate sCT images can be divided by
their approaches into three categories: bulk density (BD) overwrites, voxel-based
and atlas-based algorithms.
BD algorithms are the simplest and most robust algorithms. They have been the
ﬁrst algorithms investigated for sCT image generation, beginning with complete
water-equivalent (WE) overwrites of the patient anatomy (Schad et al., 1994; Chen
et al., 2004). Those approaches are very fast, since only the patient body contour has
to be extracted from the MR, however it is only sensitive to body contour changes
and not internal anatomical changes. They can also not be used for position veriﬁca-
tion, which relies on the detection of bony anatomy and comparing it to a reference.
Therefore, several studies added a BD value for (mainly manually contoured) bones
(Lee et al., 2003; Eilertsen et al., 2008; Jonsson et al., 2010). These studies showed
better dosimetric agreement with the planning computed tomography (pCT) and
enabled position veriﬁcation. But manual contouring is too time-consuming for clin-
ical routine, especially in the head and neck region. Besides bones, also air cavities
have signiﬁcant impact on dose distributions. They might be added to the sCT (Ko-
rsholm et al., 2014), but are hard to distinguish with standard clinical MR sequences
from cortical bone without manual contouring done. Most commercial solutions for
MR-based dose calculation for photon radiotherapy (as for example integrated into
combined radiotherapy and MR machines, so-called ”MR-linear accelerator (linac)”)
are applying BD methods, as described for example in Tyagi et al. (2017).
From this approach, sCT generation developed into two directions. One is atlas-
based, which uses the information from a library of CT and MR image pairs (the
”atlas”) to generate sCT images from MR, i.e. by deformation of atlas-CTs to
the anatomy of the incoming MR (Uh et al. (2014); Demol et al. (2016); Kraus
et al. (2017); a commercial solution suggested by Siversson et al. (2015)). Another,
related method is to ﬁnd small areas with similar structure(so-called ”patches”)
the incoming MR and in the atlas-MR, and then replace them patch-wise with
corresponding patches from the atlas-CT (Andreasen et al., 2015). This generates
very good sCT images, however these methods are limited by the time-consumption
and quality of the deformation and can only be as good as the atlas data. For
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patients with anatomic anomalies, for example after surgery, the algorithms produce
artefacts hindering the usability of the sCT images.
As an alternative, voxel-based methods have been developed, which are not lim-
ited to standard anatomies, but translate the MR to a sCT mostly using machine
learning methods, but also simpler translation-functions. One method that has been
evaluated in many studies, the dual model by Kapanen and Tenhunen (2012), ap-
plies a polynomial model for bones and a regression model for soft tissues, extracted
from a single MR sequence. In the beginning, bones had to be segmented by hand,
because grey value diﬀerentiation was not feasible between air and cortical bone,
until an automated segmentation (Koivula et al., 2016) was introduced.
The ambiguity between air and bone was one of the driving factors for the advance
of special sequences for MR imaging. Cortical bone has very short T2 relaxation
times, and can therefore not be distinguished from the signal-less air. Sequences
with ulta short echo time (UTE) or zero echo time (ZTE) have therefore been ex-
tensively investigated for sCT generation to measure signal from cortical bone, often
in combination with other MR sequences for better soft tissue separation (Johans-
son et al., 2011; Hsu et al., 2013; Rank et al., 2013; Zheng et al., 2015; Wiesinger
et al., 2018). It should be mentioned that these additional sequences add more
scanning time for the patient in the MR, which increases the costs and the chances
for anatomical changes between the scans.
The use of multiple MR sequence images initiated also more advanced sCT genera-
tion methods: machine learning methods of diﬀerent kinds have been applied in sev-
eral studies. Rank et al. (2013) and Hsu et al. (2013) used classiﬁcation approaches
covering the whole Hounsﬁeld scale using two MR images as input, Johansson et al.
(2011) applied a regression model.
Recently, a trend towards neural networks can be observed among the published
studies (Han, 2017; Maspero et al., 2018; Chen et al., 2018; Spadea et al., 2019).
Trained neural networks can generate sCT from incoming MR images very fast
without the need of multiple and/or special sequences, however require ideally large
training datasets with high anatomical agreement between CT and MR images.
Wiesinger et al. (2018) were the ﬁrst to use (a single) ZTE image, which allowed the
use of a simple linear function and thresholding to generate sCT images from the
MR. The UTE/ZTE images improve the separation of air and bone, however those
sequences are no clinical standard, thus need extra time for acquisition in addition
to the clinical standard sequences.
3.3. Goal of this thesis
Ideally, an algorithm to generate sCT images is fast, robust, compatible with dif-
ferent scanners/MR sequences at diﬀerent clinics, and accurate enough to detect
position or anatomical changes, which propagate to dosimetric changes relative to
22 Chapter 3 MR-based dose calculation
the pCT. Proton therapy might especially beneﬁt from MR imaging, because even
small changes in position or anatomy can lead to severe changes in dose deposition
due to the steep dose gradients. So far, machine learning algorithms (Rank et al.,
2013; Edmund et al., 2014; Zheng et al., 2015; Pileggi et al., 2018; Spadea et al.,
2019) have been applied for proton therapy, or existing algorithms were adapted
(Koivula et al., 2016; Maspero et al., 2017). Compared to photon therapy, there has
been no systematic increase in complexity of the algorithms as it could be expected
from the increased susceptibility to changes.
At the same time, it is not clear whether more complex algorithms are necessary
for the application of sCT images. It cannot easily be estimated if an increase of
algorithm complexity is equivalent to an increase in quality of the sCT. However,
the granularity of the sCT as a substitute for complexity can be investigated. Gran-
ularity depicts the number of BDs in the sCT image. The lowest granularity has
a sCT image with one BD, as for example a WE image. The highest granularity
covers the full range of CT numbers, as all voxel-based algorithms do.
In this thesis, the necessary granularity for sCT images in proton therapy is inves-
tigated. The investigation is performed in two steps:
1. The ﬁrst step reduces the granularity of pCT images without the use of MR
images. This procedure allows to identify tissue classes, that have a signiﬁ-
cant impact on the dose distribution, and that should be identiﬁed in the MR
image. The idea is to replace diﬀerent segments of the pCT with BD values,
starting from one BD value for the whole body and then gradually increase
the number of BDs corresponding to diﬀerent classes of tissue. The less BDs
an image has, the more robust is the image and the algorithm to create it.
The direct, voxel-wise comparison of such an bulk density computed tomogra-
phy (BD-CT) to the pCT, for example using the mean absolute error (MAE)
as a metric (cf. 4.5.1), will naturally be poor. For this reason, the quality
of the BD-CT is evaluated based on re-calculations of the dose distribution
(DD), which has been optimized using the pCT as the gold standard.
2. Based on the results of the granularity investigation, respective tissue classes
are segmented from the MR image and replaced with BD values. Both the
original MR image, and the deformably registered MR image were used as
input for sCT generation. Neglecting distortions of the MR image, this allows
to quantify the impact of anatomical changes between pCT and MR acqui-
sition. In addition, the MR image is also corrected for intensity variations
across the image (cf. section 4.4). The necessity of this correction is inves-
tigated and its impact quantiﬁed. All sCT images are compared to the pCT
and the respective BD-CTs.
The workﬂow is summarized in the ﬂowchart in ﬁgure 3.1.
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Figure 3.1.: Processing of the clinical data (green boxes) used as inputs for the work-
ﬂow.
The workﬂow was implemented such that a modular framework for BD-CT or
sCT generation and analysis was generated. This enables easy adaption to various
datasets and diﬀerent treatment modalities. In the future, it also allows to repeat
the investigation, when individual modules have been exchanged. An exchange of
modules might be necessary, if for example the module that generates sCT images
from MR images is adapted to a new algorithm or new input images.
As a ﬁrst step, the analysis was performed for photon therapy using a dataset
acquired during the MR guidance study performed at the German Cancer Research
Center. This step serves as a reference of plausibility of results, as much literature
is published for photon therapy.
The analysis of BD-CTs for proton therapy was performed successively on two
datasets: the Heidelberg Ion-Beam Therapy Center (HIT) dataset and the Gold
Atlas dataset. The HIT dataset contains CT images and treatment plans from pa-
tients irradiated at the HIT, however no MR images. The Gold Atlas dataset is a
publicly available data set (Nyholm et al., 2018) containing CT and MR images,
however no treatment plans. The latter have been created manually on the CT
images to repeat the BD-CT study also on this dataset. The results of the BD-
CTs from the HIT dataset thus serve as benchmark of plausibility of the treatment
plans. The MR images contained in the Gold Atlas dataset are the basis for the
sCT generation.
The re-calculation of the nominal treatment plan from the pCT on ﬁrst the BD-CT
and second the sCT images makes it partly possible to quantify the errors of diﬀerent
sources. The BD-CT has the exact same anatomical conﬁguration as the pCT, thus
the diﬀerence in dose distribution is solely due to the BD overwrites. Assuming an
MR image with little artefacts and the same anatomy, only the algorithm to detect
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the tissue classes for BD overwrite introduces errors in addition to the pre-quantiﬁed
errors of the BD values. The one or the other can then be reﬁned upon demand.
4. Material and Methods
4.1. Patient data
Three diﬀerent datasets with anonymised patient data were used in this study for
the three steps of investigation described in the chapter above. The ﬁrst one focused
on the applicability of bulk density computed tomographies (BD-CTs) for intensity-
modulated radiotherapy (IMRT), therefore only computed tomography (CT) and
clinical IMRT plans were needed, which was available in the so-called ”magnetic
resonance (MR) guidance” dataset. For the second step, the analysis of BD-CTs for
proton therapy, ideally clinical treatment plans are used to avoid a bias of results due
to unrealistic treatment plans. Thus, clinical data from the Heidelberg Ion-Beam
Therapy Center (HIT) was used. For the third step, the generation of synthetic
computed tomography (sCT) images from MR, MR images are a crucial requirement
of the dataset. For this reason, the open-source Gold Atlas dataset was used.
MR guidance study
The ﬁrst part of this thesis investigated the impact of BD-CTs in IMRT. The data
used for this part was part of the so-called ”MR guidance” study (Bostel et al., 2014,
2018) conducted at the German Cancer Research Center. In this study, patients
received regular MR imaging before the treatment and where then transported to
the treatment site with a shuttle to avoid anatomical changes due to re-positioning
on the treatment couch. From this dataset, six pelvic patients were selected for the
analysis. Each dataset included a planning computed tomography (pCT), contoured
target and organ at risk (OAR) structures, and a clinical IMRT plan. Details for the
indication, prescribed dose and fractionation scheme can be found in table 4.1.
A common set of delineated structures is available for the six patients, on which
structure-speciﬁc analysis is performed: the planning target volume (PTV), and
the bowel, urinary bladder and spinal cord as OARs. Other desirable structures
for analysis, such as the clinical target volume (CTV), are not available for all
patients.
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Table 4.1.: Indication, fractionation scheme (number of fractions times prescribed
dose per fraction) and number of beams for IMRT treatment for the
patients from the MR guidance study.
Patient Indication Fractionation scheme Number of beams
MRG1 Rectum carcinoma 5 x 5 Gy 7
MRG2 Rectum carcinoma 28 x 1.8 Gy 7
MRG3 Rectum carcinoma 28 x 1.8 Gy 8
MRG4 Prostate carcinoma 34 x 2.25 Gy 12
MRG5 Cervix carcinoma 28 x 1.8 Gy 9
MRG6 Anal carcinoma 28 x 1.8 Gy 9
HIT data
For the BD-CT analysis for proton therapy, four patients treated for prostate can-
cer and one patient treated for cervical cancer at the HIT were used. Each pa-
tient dataset included a pCT, contoured target and OAR structures, and a clinical
intensity-modulated proton therapy (IMPT) plan. The prostate cancer patients
were treated with two opposing beams (cf. ﬁgure 4.1) and a 26 x 2.7Gy(RBE)
fractionation scheme; the cervical cancer patient was treated with V-shaped beam
conﬁguration (cf. ﬁgure 4.2) with beam angles 160° and 200° (with 0° deﬁned
as 12 o’clock in the ﬁgures, going clockwise) and a fractionation scheme of 28 x
1,8Gy(RBE). An overview of the speciﬁcations of each patient can be found in table
4.2.
Table 4.2.: Indication, fractionation scheme (number of fraction times prescribed
dose per fraction) and beam angles for the IMPT treatment for the pa-
tients treated at HIT.
Patient Indication Fractionation scheme beam angles
HIT1 Prostate carcinoma 26 x 2.7 Gy(RBE) 90°/270°
HIT2 Cervix carcinoma 28 x 1.8 Gy(RBE) 160°/200°
HIT3 Prostate carcinoma 26 x 2.7 Gy(RBE) 90°/270°
HIT4 Prostate carcinoma 26 x 2.7 Gy(RBE) 90°/270°
HIT5 Prostate carcinoma 26 x 2.7 Gy(RBE) 90°/270°
Gold Atlas
The Gold Atlas project (Nyholm et al., 2018) provides publicly available datasets of
19 patients (18 prostate carcinoma, 1 rectal carcinoma) in total, acquired at three
sites in Sweden. In this study, patients from the Gold Atlas dataset are denoted as
GA1.x (x = 1-8) for site 1, GA2.x (x = 1-7) for site 2, and GA3.x (x = 1-4) for
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Figure 4.1.: Dose distribution in color-overlay on CT image of a prostate cancer
patient from the HIT dataset.
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Figure 4.2.: Dose distribution in color-overlay on CT image of a cervical cancer
patient from the HIT dataset.
4.2 Treatment planning tool: matRad 29
site 3. The datasets contain T1- and T2-weighted MR images, CT images, a rigid
registration between CT and MR, a deformably registered CT to MR image, and
contours of organs of interest. The speciﬁcations (B0 ﬁeld strength, TE and TR
times, etc.) of the MR images vary slightly from site to site, details can be found
in Nyholm et al. (2018). The most important diﬀerence between the three sites is
that at site 1 and 3, the B0-ﬁeld strength of the scanner is 3T, whereas at site 2 it
is 1.5T. In addition, the T2-weighted MR images hold multi-observer delineations
from ﬁve diﬀerent clinicians and consensus delineations of organs; in the CT image,
only the body contour and the bladder are delineated. The original delineations
from the T2-weighted MR images where copied to the T1-weighted MR images for
the structures used for the sCT images derived from the original MR images. For
each site, a parameter ﬁle for the deformable registration in elastix (Klein et al.
(2010), cf. section 4.3) is available. This was used to deformably register the T2-
weighted MR (and its delineations) to the CT. This was a necessary pre-processing
step for optimizing dose distributions on the CT. From the deformed delineations,
the prostate was used as the CTV. An isotropic dilation of the CTV by 5mm was
performed to create the PTV. The overlap of the 1mm isotropic dilation of the PTV
and the rectum was deﬁned as the rectal anterior wall, the remaining rectal volume
as rectal posterior wall. The body contour and bladder contour of the CT were used
instead of the deformed ones for higher agreement. An example of these target and
OAR deﬁnitions is shown in ﬁgure 4.3.
4.2. Treatment planning tool: matRad
matRad is an open-source treatment planning tool (Wieser et al. (2017), https:
//github.com/e0404/matRad) for educational and research purposes developed at
the German Cancer Research Center. In this thesis, it is used for plan optimization
and dose re-calculation, as well as a platform for additional developments. Scripts
and workﬂows in this thesis, for example the generation of synthetic CT images, are
integrated into the matRad environment.
matRad is written in matlab (The Mathworks, Inc., https://mathworks.com) and
oﬀers both a graphical user interface and command line interaction for more eﬃ-
cient work with larger data sets or standardized workﬂows. It supports intensity-
modulated photon, as well as scanned proton and carbon ion beam radiotherapy.
The workﬂow of a general matRad calculation can be explained on the basis of
the matRad variables. At ﬁrst, an image has to be imported from the Digital Imag-
ing and Communications in Medicine (dicom) dataa, which is the standard format
for storing medical image data. Image data, dose distributions, organ delineations,
dose prescription, and many more relevant information can be stored in the dicom
ahttps://www.dicomstandard.org/
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Figure 4.3.: Example slice from one patient of the Gold Atlas dataset (Nyholm et al.,
2018), illustrating the deﬁnition of target (CTV, PTV) and organ at risk
(rectal anterior and posterior wall) delineations.
format. From the dicom ﬁle a ”ct” structure is created, which contains the image
cube and meta data (e.g. resolution, cube dimension, etc.). Within matlab, this can
also be manipulated, for example when replacing the CT with a sCT. In the ”cst”
structure, the volumes of interest are deﬁned. Next, the plan parameters can be
imported from dicom ﬁle or manually set to the ”pln” structure, including amongst
others beam and gantry angles, and particle type. Based on these three inputs,
a steering structure ”stf” is generated, which contains detailed information about
each beam (consisting of multiple pencil-beams) used in the plan, such as position,
energy, beam source points and target points of the pencil-beams. This information
can be read from a dicom ﬁle if available, or it can be calculated based on ct, cst and
pln information. matRad utilizes an inverse planning approach, therefore the dose
inﬂuence matrix ”dij” or Dij, which describes the inﬂuence of a pencil-beam ”j” on a
ﬁnite volumetric element (i.e. on a voxel) ”i” for all pencil-beams of the plan and all
voxels in the image, is calculated. The dose in voxel ”i” can then be calculated as in
equation 2.13. The size of all pencil-beam ﬂuences within wj has to be optimized in
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a next step using an iterative optimization algorithm, to achieve a dose distribution
that satisﬁes all prescriptions to the target volume and constraints to OARs deﬁned
by the clinician. After optimization, ﬁnal dose distributions and the ﬂuences wj are
saved in the ”resultGUI” structure. wj can be used for re-calculating an optimized
dose distribution on a diﬀerent CT image. Therefore, Dij has the be calculated for
the new image, the ”re-calculation” is then a single matrix multiplication of the new
Dij from the diﬀerent CT image and the old wj optimized on the original image.
Furthermore, matRad contains many analysis scripts, for example to calculate dose
volume histogram (DVH) curves or gamma analysis (both cf. section 4.7). Since
many processes have been automated or adapted in this thesis, only the command
line interaction was used and workﬂow scripts based on matRad functions were
created.
4.3. Rigid and Deformable Registrations
Independent from the chosen method to create synthetic CT images, image registra-
tion is always necessary. Image registration is the process, that brings two images
(from diﬀerent time points, of diﬀerent modalities, etc.) to best spatial agreement.
Rigid registrations, i.e. translation and rotation of images, are necessary to overlay
CT and MR images from diﬀerent, machine-dependent spaces. Often, rigid regis-
trations alone are not suﬃcient, since they can not describe anatomical changes as
they can occur with organ motion or weight loss. For this purpose, deformable reg-
istrations have been developed, which aims at matching anatomical structure over
each other by locally deforming the image. Any registration consists of three main
parts (Oh and Kim, 2017): an optimization algorithm, a similarity measure and a
transformation model. The optimization algorithm tries to maximize the similarity
measure between the ﬁxed image and the moving image (i.e. the one whose struc-
ture will be changed to match the ﬁxed image), which has been deformed according
to the transformation model.
Generally, the transformation model is not invertible as it is not a bijective map-
ping. The most common similarity measures are the sum of (voxel-wise) squared
diﬀerences for mono-modal registration, i.e. for registrations between two images
of the same modality such as CT to CT, and mutual information for multi-modal
registration, i.e. for images of two diﬀerent modalities, such as CT to MR.
For the MR and CT data sets of the Gold Atlas (cf. section 4.1), a rigid transforma-
tion is available with the data, which was applied in this study as is. Additionally,
the Gold Atlas also provides CT images, which have been deformably registered to
the MR, and the corresponding parameter ﬁles for the registration. In this thesis,
however, a deformable registration of the MR to the CT was needed (i.e. ﬁxed and
registered image switched), therefore the parameter ﬁles were used to generate new,
registered MR images. The workﬂow of the Gold Atlas registration was followed
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as described in Nyholm et al. (2018) (described in full detail in appendix A), only
the registered and ﬁxed images were switched. Brieﬂy, the urinary bladder contours
from the MR and CT images are added in binary format to the registration input,
as well as the CT body contour to mask the region of interest. The registration is
performed on three levels of resolution for more robustness, from coarse to original
resolution. The registration algorithm uses a BSpline approach (i.e. the deformation
can be described with continuous, piece-wise polynomial functions), which is inde-
pendent from complete segmentation of the input images. As similarity measures,
mutual information is applied for the CT/MR comparison, whereas for the bladder
binaries, mean squared diﬀerences are calculated. The output of the algorithm is a
transform ﬁle, specifying the BSpline-parameters of the deformation, which is then
applied to the MR image and all binary segmentations of the MR. The registration
was performed using the elastix software packageb (Klein et al., 2010).
4.4. Bias Field Correction
One MR artefact mentioned in section 2.1, which does not aﬀect the anatomical
information of the image and therefore generally is not corrected for, is the low
frequency non-uniformity of the image. It originates from an inhomogeneity of the
ﬁelds produced by the radio-frequency (RF) coils or inhomogeneity of the ~B0-ﬁeld of
the scanner, therefore the expression of the artefact is proportional to the strength of
the ~B0-ﬁeld. It does, however, aﬀect quantitative use of the image, since grey values
alone are not suﬃcient any more for same tissue identiﬁcation. The most common
algorithm to correct this artefact is the N4 bias ﬁeld correction (BFC) algorithm
introduced by Tustison et al. (2010). It is implemented in the open-source medical
image processing software Slicer c, which was applied in this thesis for this purpose.
The corrective bias ﬁeld, or the corrected image, is obtained in an iterative process.
Based on the assumption that a (noise-free) measured image v(~x) is a product of
the uncorrected images u(~x) and the smooth, slowly varying bias ﬁeld f(~x):
v(~x) = u(~x)f(~x). (4.1)
Using the notation v̂ = log(v), this becomes
v̂(~x) = û(~x) + f̂(~x). (4.2)
The solution for the corrected image û(~x) in the nth iteration of the BFC algorithm
is calculated as
ûn = ûn−1 − f̂nr
= ûn−1 − S ∗ {ûn−1 − E[û|ûn−1]},
bhttp://elastix.isi.uu.nl/
chttps://www.slicer.org/
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where f̂nr is the residual bias ﬁeld (i.e. the bias ﬁeld needed to correct the updated
image ûn−1 from the previous iteration), S ∗ {·} denotes a B-spline approxima-
tor, which satisﬁes the requirement of a smooth and slowly varying bias ﬁeld, and
E[û|ûn−1] is the expected value of û given the current estimate of the corrected
image (ûn−1). The total bias ﬁeld is then the sum of the residual bias ﬁeld of each
iteration. An example for an MR with bias ﬁeld, a corrective bias ﬁeld and the
corrected MR is given for one patient of the Gold Atlas data set in ﬁgure 4.4.
Bias ﬁeld correction was applied in this thesis to all used MR images, to investigate
the inﬂuence of this image pre-processing step on the quality of the sCT images.
Figure 4.4.: (a) T1-weighted MR image from the Gold Atlas dataset. (b) Bias ﬁeld
of MR image. (c) Bias ﬁeld corrected MR image.
4.5. Own developments for this thesis
4.5.1. Bulk Density Computed Tomographies
The term ”synthetic CT” implies that it is a general goal to produce images, which
look indistinguishable from an original CT image. This fact is strongly reﬂected by
the metrics used for evaluation: one of the most commonly reported metrics is the
mean absolute error (MAE) between the CT and the sCT (Edmund and Nyholm,
2017):
MAE =
1
N
N∑
i=1
|sCT (i)− CT (i)|, (4.3)
with N the total number of voxels in the images, and sCT (i) and CT (i) the HU
values at voxel i, respectively. It is, however, not clear whether it is necessary for
dose calculation to reproduce over 4000 diﬀerent grey values for clinically comparable
dose distributions.
The motivation for this question can be explained with the help of a histogram
of rED numbers, i.e. the grey value of the voxels in the CT converted using a
Hounsﬁeld look-up table (HLUT), as seen in ﬁgure 4.5 for the body contour of a
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pelvic cancer patient. Two peaks are clearly dominant: the one around rED ∼ 0.95
represents fat, the one around rED ∼ 1.05 represents soft tissues.
This seems reasonable considering that the shape is determined by two factors: the
distribution of true CT numbers of the tissue and by artefacts, most dominantly
noise, which are Gaussian shaped (Diwakar and Kumar, 2018). For proton therapy,
the sum of the stopping power ratio (SPR) values (for photon therapy the relative
electron density (rED) values, respectively) inside the voxels along the path of the
beam determine the particle range for a ﬁxed energy. If these SPR and rED values
vary symmetrically around a mean, than the sum of them is equal to the summation
of the mean values. This assumption can be made for Gaussian distributions, as
they are symmetrical.
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Figure 4.5.: Histogram of the rED numbers within the body contour of one patient
from the MR guidance dataset. The lines indicate the thresholds for
used for tissue segmentation. Air is segmented below the dotted line,
between the dotted and the solid line is fat, between the solid and the
dashed line is non-fatty soft tissue (st), above that bone which is further
slit at the dotted-dashed line in soft and hard bone.
To address the question of the necessary number of bulk densitys (BDs), the number
of BDs in the pCT was varied starting from the maximum reduction comprising only
one class. As measure of quality, the original dose plan was re-calculated on the CT
containing the BD classes (BD-CTs) and compared to the original.
The pCT was segmented into tissue classes based on its grey values. The segmen-
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tation into ﬁve classes was executed in the following steps:
1. Bone was pre-segmented above SPR = 1.089 and rED = 1.069, respectively,
producing a skeleton of the bone segment. Since this does not generally cover
soft bone, which has lower grey values due to its high fat content, the resulting
bone contours were ﬁlled using morphological operations:
a) Small gaps of maximum 3 pixels (which might for example occur where
the cortical bone is very thin) were closed, so the segmentation skeleton
is fully connected.
b) The skeleton was ﬁlled to remove the hollow parts
c) Single pixels or small clusters of pixels were removed. Those single pixels
or clusters might have be included to the segment during the application
of the SPR = 1.089 and rED = 1.069 threshold, for example where small
metallic implants have been used as position markers.
d) Within the complete bone segmentation, voxel above SPR = 1.4 and rED
= 1.217, respectively, were classiﬁed as cortical bone, the remaining part
was classiﬁed as spongy bone.
2. SPR = rED = 0.6 inside the body contour was assigned air.
3. Based on the histogram, for each patient the minimum position between the
fat and the soft tissue peak was determined as the optimum splitting point for
those tissue classes (more details how this point was determined can be found
in the following section on BD value determination).
4. Tissue below the splitting point and above the air threshold was assigned fat.
5. Tissue above the splitting point that is not bone was assigned soft tissue.
For the BD-CTs with diﬀerent granularity, the segments were assigned diﬀerent BD
values. For the investigation for conventional IMRT with photons, four diﬀerent
BD-CTs were created with one to four BDs: (1) one water-equivalent, (2) one single
BD, (3) one with two BDs for fat and soft tissue, and (4) one with four BDs for fat,
soft tissue, air and bone. With knowledge of the results from BD-CTs for the photon
plans, the BD-CTs were adapted subsequently for the proton plans. Here, BD-CTs
with two BDs or less were omitted. One BD-CT with four BDs (air, fat, soft tissue,
bone) and one with ﬁve BDs (air, fat, soft tissue, spongy bone, cortical bone) were
created. In addition, BD-CTs with original content (either bone or soft tissue were
left as in the pCT) were created, to investigate the inﬂuence of the diﬀerent BD
groups. An overview over all BD-CTs can be found in table 4.3.
The BD numbers to overwrite the diﬀerent segmentations in the photon study were
chosen to be patient-speciﬁc rED values for fat and soft tissue, and ﬁxed values for
air and bone. For the proton study, patient-speciﬁc SPR values were used for each
BD. From a clinical point of view, the CT image as a trustworthy reference will not
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Table 4.3.: Overview over the diﬀerent bulk density (BD)-CTs created for intensity
modulated radiotherapy with photons (top) and proton therapy (proton).
For each BD-CT (rows), the content of the segmented classes (columns)
is given: ”BD” refers to a bulk density overwrite value for the whole
segment, ”pCT” refers to the original content from the pCT.
air fat soft tissue spongy bone cortical bone
segment segment segment segment segment
photon
WE BD
1t BD
2t BD BD
4t BD BD BD BD
proton
WE BD
ST pCT BD BD pCT pCT
B1 pCT pCT pCT BD
B2 pCT pCT pCT BD BD
STB1 BD BD BD BD
STB2 BD BD BD BD BD
be abandoned in the near future. Thus, patient-speciﬁc BD values will be available
in all cases.
4.5.2. Determination of bulk density values
The BD overwrite values for the BD-CT images (explained in the previous section)
have to be determined from the image. In this thesis, a ﬁtting approach of the
rED and SPR histograms for photon and proton therapy, respectively, has been
chosen. After conversion of the pCT image using the clinical HLUT as explained
in section 2.3.1 and 2.3.2, the rED and SPR values were only analysed within the
body contour delineated by the physicians. The two dominant peaks representing
fat and soft tissue (st), as can be seen in the rED histogram in ﬁgure 4.6 for a patient
treated with photons, are ﬁtted with a sum of two Gaussian functions (orange line),
a so-called two-termed Gaussian function:
G(x) = c1 · exp(−(x− µfat)
2
2σ2fat
)) + c2 · exp(−(x− µst)
2
2σ2st
)) (4.4)
The mean values µfat and µst correspond to the peak positions (dotted and dashed
purple lines). Potential noise or artefacts in the image are neglected this way. To
separate the two tissue classes fat and soft tissue, the minimum point between the
two Gaussian functions was determined as a threshold (solid purple line).
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Figure 4.6.: Example of relative electron density histogram (blue) and ﬁt of the two
peaks using a two-term Gaussian function (orange). The peak positions,
i.e. the µ ﬁt parameter of the Gaussian functions, for fat (dotted line)
and soft tissue (dashed line), and the threshold used for grey-value based
separation of the two tissue classes (solid line) are shown as vertical lines
at respective relative electron density values.
The usage of BD values as overwrite values for tissue classes was one of the earli-
est investigated methods to create sCT images. How these BD values are derived
changes from study to study. Most commonly, mean values (Lee et al., 2003; Doe-
mer et al., 2015) of tissue classes derived from the CT image, or reference values
from International Commission on Radiation Units & Measurements (ICRU) report
published by White et al. (2016) are applied (Jonsson et al., 2010; Korsholm et al.,
2014). In this study, the peak position µfat and µst are used as BD values for the
fat and the non-fatty soft tissue, respectively. In comparison to the usage of mean
values or reference values, the ﬁt approach has certain advantages. First, it is in-
dependent from pre-segmentation of the individual classes, based on which average
values can be determined. Secondly, is it more robust towards artefacts or an ”over-
pronunciation” of individual rED or SPR bins, that could distort the mean value.
The usage of the ICRU report is limited in the sense that only very speciﬁc types,
e.g. the femur as surrogate of bone, are listed in that report, which do not reﬂect
the entirety of rEDs or SPRs.
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4.5.3. Generation of synthetic CTs
The sCTs derived from MR images were generated based on the T1-weighted MR
images from the Gold Atlas dataset (cf. section 4.1). The sCT generation tried to
mimic the BD-CT containing ﬁve tissue classes (i.e. air, fat, non-fatty soft tissue,
spongy bone, cortical bone). At ﬁrst, the bones were segmented via an intensity
threshold (below the red vertical line in ﬁgure 4.7), which was deﬁned as the signal
intensity on the ﬁrst rising slope of the histogram at 1/3 of the maximum height
of the corresponding peak. Due to the ambiguity of air and bone intensity values
in the MR, these two classes were separated using a bone probability mask. The
mask was generated by adding the 19 segmented bones masks from the CT image
of the Gold Atlas patients and normalizing the result. Thus, the voxels contains
values between 0 and 1, giving the cohort probability of bone in every voxel (0 - no
patient had bone in this voxel, 1 - all 19 patients had bone in this voxel). If a voxel
was segmented based on the threshold and the probability was larger than 0.5 (blue
area in ﬁgure 4.8), it was classiﬁed as cortical bone, otherwise as air.
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Figure 4.7.: Histogram of a bias ﬁeld corrected T1-weighted MR image from the
Gold Atlas dataset. The red vertical line marks the initial threshold
were air/cortical bone is separated from the remaining tissue; the black
line marks the threshold that is used to separate muscle from fat/spongy
bone.
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probability ≤ 0.5
probability > 0.5
Figure 4.8.: One slice from the probability mask for bone. The area where the
probability is > 0.5 is shown in blue, ≤ 0.5 in green.
Since spongy bone contains a lot of fat, the signal intensity is almost indistinguish-
able from subcutaneous or visceral fat. Therefore, a second threshold was applied
to separate potential fatty tissue from other soft tissue, bone and air (the black line
in ﬁgure 4.7), which was deﬁned as the minimum position between the two peaks.
Tissue above this threshold is fatty, including spongy bone, whereas tissue below,
i.e. between the red and the black vertical lines, is mostly muscle and other non-
fatty soft tissue. The bone probability mask was then used again to separate spongy
bone (probability > 0.5) from other fat (probability ≤ 0.5).
The ﬁve tissue classes segmented on the clinical MR were subsequently overwritten
with BD values, derived patient-speciﬁcally from the SPR/rED histogram. The BD
values correspond to the respective values in the BD-CT. The same procedure was
applied to the deformably registered MR (cf. section 4.3), to minimize anatomical
diﬀerences between the two images. To minimize the impact of the bias ﬁeld (cf.
section 4.4), the same procedure was also applied to the bias ﬁeld corrected MR. Fi-
nally, a sCT was generated based on a deformably registered and bias ﬁeld corrected
MR image. Thus, in total, four sCT images were generated:
• sCTO using the original MR
• sCTR using the registered MR
• sCTB using the bias ﬁeld corrected MR
• sCTBR using the registered and bias ﬁeld corrected MR
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Figure 4.9.: Examples of (a) a planning CT (pCT), (b) a bulk density CT (BD-CT),
and (c) a synthetic CT (sCT) image for the pelvis for patient GA1.1 of
the Gold Atlas dataset.
4.6 Dose calculation and re-calculation 41
4.6. Dose calculation and re-calculation
In an ideal, MR-based treatment planning workﬂow, the dose optimization and
calculation is performed on the sCT image. Taking a real CT, i.e. the pCT, as the
gold standard, the error in the dose distribution (DD) caused by the sCT image can
be analysed by a re-calculation of the DD optimized on the sCT and re-calculated
on the pCT.
In the ﬁrst part of the thesis, this approach was implemented for the BD-CT study
for photon therapy. For each BD-CT, a DD was optimized using clinical dose pre-
scriptions and constraints to imitate the clinical plan from the pCT. The beam
weights from the clinical plan was used for beam weight initialisation during each
optimization, to achieve as similar DDs as possible. A 1%/1mm gamma analysis
(explained in section 4.7) was performed to compare the DD from the pCT (DDpCT)
and the DD from the BD-CTs. All comparisons yielded a 100 % gamma pass rates
(GPRs) in the PTV and inside the volume that receives more than 2 % of pre-
scribed dose, thus the DD from the BD-CTs are considered equal to the DDpCT.
In a next step, these DD are re-calculated on the pCT using the beam weights wj.
Depending on which BD-CT the DD was optimized on, the re-calculated DD are
labelled DDBD-CT. For example: the DD optimized on BD-CTWE is called DDWE
after re-calculation on the pCT.
The same approach is not feasible for proton therapy, for eﬃciency reasons. The
optimization of a proton treatment plan is more time-consuming, as the plan has
many more degrees of freedom. For this reason, the DD of the pCT was re-calculated
on the BD-CTs. The resulting DD is also labelled DDBD-CT, although it should be
noted that the eﬀect of the BD-CT on the dose diﬀerence is now reversed: a de-
crease in radiological depth in the BD-CT would lead to an undershooting of the
proton beam when re-calculating the BD-CT-based plan on the pCT, whereas for
the re-calculation of the pCT-based plan on the BD-CT, the proton beam would
overshoot.
For the HIT dataset, the clinical treatment plan was re-calculated within matRad
and the resulting DD was used as the reference DDpCT. It was then re-calculated
on the BD-CTs. The reference DD for the Gold Atlas dataset had to be optimized
manually, as no clinical data was published. The optimization was performed us-
ing prescriptions and constraints as they are applied at the HIT facility, to create
realistic DDs.
The DDpCT created for the Gold Atlas dataset have also been used for re-calculations
in the sCT images. These DDs are labelled DDO, DDR, DDB and DDBR, respec-
tively.
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4.7. Analysis Metrics
Metrics in this thesis were selected to describe the DD after forward-calculation of
the nominal dose on the BD-CTs/sCTs. DVHs were chosen, since they are widely
used for dose prescription for targets and dose constraints for OARs. Thereby,
diﬀerences of these criteria using BD-CTs/sCTs instead of the pCT can directly be
detected. By nature, DVHs give no information on the location of observed dose
diﬀerences, therefore the gamma analysis (cf. equation 4.5) is added, which oﬀers
location information, but also yields generalised results via GPR. As a last metric,
the proton range analysis is included. A change in proton range, i.e. of the Bragg
peak position, will shift the position of highest dose deposition, worst case it will
be shifted to healthy tissue and miss the tumour. Proton range analysis creates
two-dimensional (2D) range diﬀerence plots and mean values for comparison among
larger data sets.
Dose Volume Histograms and Dose Volume Metrics
Dose volume metrics (DVMs), derived from cumulative DVHs, are the most common
measures to evaluate a given DD, but are also used for dose prescription to the target
or normal tissue constraints. In such a histogram, the volume which receives at least
a certain dose is plotted for selected structures. DVM then refers to dose in a speciﬁc
volume, for example: D50 is the minimum dose, that 50 % of the volume receive.
Certain DVMs are used as indicator for speciﬁc DDs: the D2 is an indicator of
hotspots, and D98 is an indicator for the coverage of the structure with dose. The
reference volume (corresponding to 100 %) can be the whole body, but also smaller
volume of interests (VOIs), such as the target volume or OARs. An example for
DVH curves of a target volume and an OAR (rectum in this case) is shown in ﬁgure
4.10 for one prostate cancer patient treated with protons at HIT.
Gamma Analysis
Gamma analysis is a common tool for comparison of two DDs, not only for treat-
ment plan comparisons, but also for example during quality assurance to compare
a simulated plan to a measurement. It incorporates not only dosimetric diﬀerences,
but rather a ”distance to agreement”, meaning that the dose is compared not only
in the exact same position, but within a pre-deﬁned radius around the reference
position. The gamma index γ(~r) was ﬁrst introduced by Low et al. (1998) as
γ(~r) = min{
√
|~rc − ~r|2
∆r̂2
+
(dc(~rc)− d(~r))2
∆d̂2
,∀~rc}. (4.5)
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Figure 4.10.: Dose volume histograms for the planning target volume (PTV) and
the rectum as an organ at risk for a patient treated for prostate cancer
at HIT with a prescribed dose of 2.7Gy(RBE) per fraction.
~rc and dc are the position and the dose to compare to, respectively, ∆r̂ and ∆d̂ are
the pre-deﬁned radius in geometrical and dosimetrical space, serving as acceptance
threshold for the gamma pass criterion:
γ(~r) ≤ 1, passesγ(~r) > 1, fails (4.6)
As the gamma index is calculated for each voxel of the reference image, a three-
dimensional (3D) gamma index cube is created, which can be analysed visually.
An example of one slice of a gamma index cube is shown in ﬁgure 4.11 overlaid
onto the corresponding slice of the pCT, which was used as the reference. The
percentage of voxels within a certain volume that pass the criterion is called the
GPR. Typical values for ∆r̂/∆d̂ are for example 2mm/2% or 1mm/5%. The latter
criterion penalizes geometrical deviations stronger than dosimetrical deviations. The
distribution of gamma values can also be plotted as 3D maps to visually correlate
failure and position.
Generally, two types of gamma values can be distinguished: local and global values.
The diﬀerence is the reference for ∆d̂, which could either be the dose at the investi-
gated (local) position, or the (global) maximum dose. In this thesis, only the global
gamma value is used. As a consequence, only areas with a dose larger than ∆d̂ are
included in the analysis.
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Figure 4.11.: Two-dimensional example of the gamma analysis performed using
2mm/2% criteria for BD-CTWE of patient HIT1 overlaid onto the cor-
responding CT slice.
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Proton Range Analysis
For the analysis of the range of the proton beam covering the target, the distal
range for each bixel is extracted from the DD as the geometrical depth along the
beam to the point where the dose distal to the dose maximum drops to 50 %. This
point is dominated by the proton beam with the highest energy in that bixel. The
range is then called R50. To quantify the changes of range compared to the pCT
and the respective original DD, the diﬀerences between R50pCT and R50BD−CT/sCT
are calculated bixel-wise. In addition, the mean and the standard deviation of
the absolute diﬀerence of all pencil-beams of the plan are calculated to make the
results more comparable among patients and BD-CTs/sCTs. In doing so, spatial
information is lost and no correlation between anatomy and range shifts can be
drawn. Therefore, 2D plots of the range shifts per beam in beam’s-eye-view (BEV),
are generated. An example of such a 2D range shift plot between pCT and a BD-CT
with ﬁve BDs is shown in ﬁgure 4.12 for a prostate cancer patient treated at HIT.
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Figure 4.12.: 2D plot of the pencil-beam-wise range diﬀerences between the planning
CT and the BD-CT with ﬁve BDs for a patient of the HIT data. The
diﬀerence is color-coded.
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4.8. Uncertainty Sampling
Simulation of uncertainties during treatment planning is of interest in the ﬁeld for
a long time in the context of plan robustness. A robust plan does not change
critically under realistic changes, such as changes in position or range. A good
nominal treatment plan is not necessarily a robust plan, therefore simulation of a
set of possible uncertainty scenarios (”uncertainty sampling”) becomes necessary to
evaluate and compare its robustness.
For position changes (i.e. ”set-up uncertainties”) in photon therapy, this task can
be solved under the assumption, that the DD does not change signiﬁcantly under
shift as proposed in Witte et al. (2007), i.e. instead of re-calculating the dose on the
CT shifted by a shift vector, the dose can be shifted by the shift vector inversely.
This approach is very time eﬃcient, since the plan does not have to be re-calculated,
instead only the evaluation metrics have to be calculated for the shifted dose.
For proton therapy, this assumption can certainly not be made and the most straight-
forward possibility is to re-calculate the nominal DD on each shifted CT (Mu¨ller,
2016). In this thesis, only pelvic patient data were analysed, therefore the shift
vectors were randomly sampled with a standard deviation of the vector magnitude
of σ = 2 − 3mm following van Herk (2004). Automated tools to sample the shift
vectors, do the re-calculation and the analysis was fully implemented in a matRad
branch (dev varRBErobOpt) by Mu¨ller (2016), which was used in this thesis for
the uncertainty sampling of the proton cases.
For each sampled CT image, the DDs from the set-up uncertainty sampling are
analysed using the same analysis metrics as for the nominal CT image. For each
analysis metric, the uncertainty samples form a set of values, that is visualized in
this thesis using boxplots, given the interquartile range (IQR) as the outer box, and
the median value as the central line.
In addition to set-up uncertainties, also radiological depth (rD) uncertainties (cf.
section 2.3) have been simulated. For this purpose, the rD for each pencil-beam
was up- or down-scaled by 1.5 % consistently over the underlying image while re-
calculating the nominal dose plan. For the proton cases, this is also implemented in
the uncertainty sampling tool in matRad.
For visualization of the impact of the rD uncertainties on the DD, vertical lines,
similar to error bars, are included in the analysis metrics plots.
Uncertainty sampling is performed for each pCT in this thesis. For the BD-CTs and
the sCTs, only rD uncertainty sampling is performed, as the set-up uncertainty is
the uncertainty which ideally will be strongly reduced by the use of MR image prior
or during treatment.
The uncertainty sampling of the pCT images additionally have a special assignment:
they are used as an ”acceptance band” of analysis metrics for the BD-CTs and sCTs.
The sum of the IQR of set-up samples and the range of rD samples create a range of
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analysis metric values, which are considered acceptable for the BD-CTs. An example
showing the acceptance band in green, the IQR as a boxplot, the rD range as an
error bar for arbitrary data in ﬁgure 4.13.
Figure 4.13.: The acceptance band shown in green, created from the range of the
boxplot and the errorbar representing the uncertainty sampling for
shifts and radiological depth (rD), respectively.

5. Results
5.1. BD-CTs for photon therapy
The following section summarizes the results of the histogram analysis used to deﬁne
the bulk density (BD) overwrite values for the bulk density computed tomographies
(BD-CTs) derived from the planning computed tomography (pCT) images of the
MR guidance dataset. Subsequently, these BD-CTs are analysed regarding their
radiological depth (rD) and dose volume histogram (DVH) diﬀerences with respect
to the pCT, and gamma analysis. In the discussion, the results are evaluated in
consideration of the extension to proton therapy, and set into context to literature
values.
Histogram analysis
The results of the peak and threshold ﬁtting (cf. section 4.5.2) of the relative
electron density (rED) histogram are summarized in table 5.1. The mean rED of
the fat peak position µfat over the six patients is 0.934±0.008. The respective value
of the soft tissue peak position µst is 1.027± 0.005. The mean threshold rED value
is 0.973± 0.004.
Table 5.1.: Mean values µ of the two-termed Gaussian function ﬁtted to the relative
electron density histogram of the planning CT for each patient of the
MR guidance dataset. Each Gaussian peak represents one of the two
dominant tissue classes fat and soft tissue (st). The minimum between
the two peaks is used as a threshold to separate the two classes.
rED µfat µst threshold
MRG1 0.931 1.019 0.970
MRG2 0.948 1.029 0.980
MRG3 0.933 1.029 0.974
MRG4 0.932 1.034 0.973
MRG5 0.924 1.026 0.970
MRG6 0.936 1.026 0.972
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The values of µfat and µst from the table are used as overwrite values for the BD-
CT images as summarized in section 4.5.1. The BD-CTs are labelled according to
the number of BD values that they contain. In total, four BD-CTs are created:
BD-CTWE, BD-CT1t, BD-CT2t, and BD-CT4t.
Radiological Depth
The rD analysis is a ﬁrst indication where the BD-CTs can show strong dosimetric
deviations from the pCT. The rD was analysed as explained in equation 2.12 along
the pencil-beams used for dose calculation of each beam. The rD is measured from
the entrance of the beam into the patient to the point where the beam exits the
planning target volume (PTV). Thus, the diﬀerence in rD between the pCT and the
BD-CT for each beam in the treatment plan can be visualized in two-dimensional
(2D) plots. Examples for diﬀerence plots are shown in ﬁgure 5.1 for BD-CTWE, BD-
CT1t, BD-CT2t, and BD-CT4t for patient MRG1 for the beam at 0° each. Patient
MRG1 was treated for rectum carcinoma with seven beams in total. For the BD-
CTs with one or two BD values, anatomical features such as the pelvic bones or an
air bubble in the intestine cause large negative or positive diﬀerences, respectively.
In contrast, for the BD-CT4t, the overall diﬀerences decreased in a way hardly any
of these features are distinguishable.
(a) pCT - BD-CTWE (b) pCT - BD-CT1t (c) pCT - BD-CT2t (d) pCT - BD-CT4t
Figure 5.1.: 2D plots of the pencil-beam-wise radiological depth diﬀerences between
the pCT and (a) BD-CTWE, (b) BD-CT1t, (c) BD-CT2t, and (d) BD-
CT4t, respectively, for patient MRG1 for the beam at 0°.
The mean absolute diﬀerences over all pencil-beams of all beams were compared
among the diﬀerent BD-CTs as summarized in table 5.2. The BD-CT1t yields the
largest mean absolute diﬀerences for all patients and the largest standard deviations
for four patients. It performs generally worse than the BD-CTWE. The BD-CT4t
shows the smallest absolute diﬀerences with the smallest standard deviations for
all patients. Also the variation among the patients is much smaller, giving more
reliable results compared to, for example, the BD-CT2t, for which mean absolute
range diﬀerences between 2.8 mm and 7.3 mm occur.
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Table 5.2.: Mean and standard deviation (sd) of the absolute diﬀerence in radio-
logical depth between the pCT and the BD-CTs (cf. table 4.3) for all
pencil-beams of the treatment plan for the six patients of the MR guid-
ance dataset. The average over the six patients is shown in the last
row.
patient mean (sd) absolute rD diﬀerence [mm]
WE 1t 2t 4t
MRG1 7.0 (5.2) 11.5 (7.1) 5.9 (4.9) 2.3 (1.9)
MRG2 6.4 (5.9) 7.6 (5.9) 5.5 (6.1) 2.0 (1.6)
MRG3 8.9 (8.6) 10.8 (8.0) 7.3 (8.0) 2.2 (1.9)
MRG4 4.2 (2.7) 7.8 (3.4) 2.8 (2.1) 2.1 (1.5)
MRG5 4.2 (3.2) 5.9 (4.5) 4.6 (3.7) 1.2 (1.1)
MRG6 4.7 (4.7) 7.2 (5.4) 3.9 (4.5) 1.6 (1.6)
average 5.9 (5.1) 8.4 (5.7) 5.0 (4.9) 1.9 (1.6)
Gamma Analysis
Three-dimensional (3D) gamma analysis (cf. equation 4.5) was performed comparing
the dose distribution (DD) from the BD-CTs against the DD from the pCT. In
general, ”shadows” of failure occur behind intestinal or rectal gas for all the BD-
CTs without a BD for air. An example is shown in ﬁgure 5.2 for patient MRG2 for
the gamma analysis of DD2t compared to DDpCT. Similar behaviour is observable
more dominantly behind long paths of the beam through bone, e.g. in the pelvic
bones. This is also visible in ﬁgure 5.2 in the top left corner of the PTV. All DDs
from BD-CTs without air and bone BDs show strong inﬂuence of this behaviour.
For the DD4t, the air shadow is absent. However, a slight shadow behind cortical
bone is still visible due to the fact that only a single BD for the whole bone was
assumed, which does not reﬂect the rD after long paths through cortical bone.
The gamma pass rate (GPR) was analysed for the PTV volume. A summary is
shown in ﬁgure 5.3, with the mean GPRs of the DD from the BD-CTs of all patients
shown as symbols (dots), and the range of GPR values from the six patients as
errorbars. GPRs of 100 % were achieved for the DD4t for all patients. For the DD2t,
the lowest GPR is 96.2 % for patient MRG3. The DD1t shows the worst mean GPRs,
while DDWE shows a mean GPR of 98 %. The overall lowest GPR was observed for
patient MRG4 for the DD1t (53 %).
Dose Volume Histogram Analysis
The analysis of the DVH curves includes the analysis of the DDpCT, DDBD-CTs,
the uncertainty sampling for range and set-up uncertainties for the pCT, and the
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Figure 5.2.: Two-dimensional example of the gamma analysis performed using
2mm/2% criteria for DD2t of patient MRG2 overlaid onto the corre-
sponding CT slice.
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Figure 5.3.: Mean gamma pass rates (GPRs) using a 2mm/2% criterion for the PTV
of the DDBD-CT (dots). The ranges (minimum to maximum GPRs) are
shown as errorbars. For the DD4t, the errorbar is hidden under the
dot-marker.
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rD uncertainty sampling for the BD-CTs. The set-up uncertainty sampling of the
BD-CTs was not included, as this uncertainty would be strongly reduced using the
magnetic resonance (MR) prior or during the treatment. The DVHs are analysed
for the target volume (the PTV) and the most relevant organs at risk (OARs): the
urinary bladder, the spinal cord and the bowel.
For the quantitative analysis of the DVH curves, the dose volume metrics (DVMs)
D2, D50 and D98 were evaluated for the PTV, and the D2 and D15 for the OARs.
Table 5.3 shows the mean relative DVM diﬀerences for the PTV, the urinary bladder,
the spinal cord and the bowel. The standard deviation among the patients is shown
in brackets.
Table 5.3.: Mean relative dose diﬀerence and standard deviation (sd) of the six pa-
tients of the MR guidance dataset for the four DDBD-CTs.
mean (sd) relative DVM diﬀerences [%]
DVM WE 1t 2t 4t
PTV
D2 0.45 (1.36) -0.70 (1.16) -0.13 (1.26) 0.18 (0.29)
D50 -0.35 (0.45) -1.55 (0.38) -0.58 (0.25) 0.24 (0.24)
D98 -0.28 (0.30) -1.43 (0.45) -0.38 (0.43) 0.30 (0.46)
urinary D2 -0.97 (1.11) -2.20 (1.08) -1.11 (1.02) 0.25 (0.34)
bladder D15 -0.86 (0.93) -2.06 (0.96) -2.62 (3.83) -1.27 (3.36)
spinal D2 -0.15 (0.76) -1.88 (1.87) -0.89 (1.87) 1.05 (2.56)
cord D15 -0.16 (1.34) -1.90 (2.63) 0.12 (4.35) 2.11 (4.19)
bowel
D2 0.84 (1.21) -0.29 (1.05) -1.57 (5.37) -1.53 (4.21)
D15 0.66 (1.05) -0.60 (1.55) -0.07 (1.49) 0.14 (0.27)
None of the BD-CTs yielded DVMs that are unacceptable with respect to the QUAN-
TEC dose constraint recommendations (Marks et al., 2010).
For the PTV, the DD4t shows the overall smallest diﬀerences among the BD-CTs.
For D2, the standard deviation of the DD4t is also signiﬁcantly smaller than for
the other BD-CTs. Individual relative DVM diﬀerence values might be smaller, for
example D98 for the DDWE, but overall the DD4t shows best results for the PTV.
Among the OARs, mostly a decrease in dose is observed as indicated by the negative
relative diﬀerences. Exceptions can be observed for DD4t for all OARs, for DDWE for
the bowel, and for DD2t for the spinal cord. The overall largest relative diﬀerences
are observed for DD1t, which generally performs worse than DDWE.
A decrease in PTV dose does not necessarily correspond to an increase in OAR dose.
However, it can be expected that an increase in dose may be observed in structures
that have not been investigated here.
Figure 5.4 shows the DVMs for the PTV for patient MRG3. This patient was se-
lected for visualization, as it shows the worst results when comparing the DVMs to
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Figure 5.4.: DVMs for the DDpCT and DDBD-CTs (circles) for the PTV for one frac-
tion for patient MRG3. The result of the set-up uncertainty sampling
for the pCT is shown as a boxplot, while the range of the rD uncertainty
sampling for all images is shown as the errorbars.
the acceptance band (cf. section 4.8) among all patients, and the largest relative
deviations from the reference DD. The DVMs for the DDBD-CTs diﬀer up to a max-
imum of 3 % for the D2, DDWE has the largest deviations here. For D50 and D98,
DD1t shows the largest deviations to the DDpCT. The observed increase in D2 and
decrease in D98 (for example for DD1t) corresponds to a ﬂattening of the DVH curve
around the step gradient region. The DVMs for DD4t lie within the acceptance band
in all three cases, whereas for the other BD-CTs, exceedings of the acceptance band
can be observed for at least one DVM.
The set-up uncertainty sampling for the pCT shows that a slight error in positioning
leads to dose ”cold spots” in the PTV, i.e. a partial volume of the PTV does not
receive the prescribed dose any more. The result is that the interquartile range
(IQR) of the D98 values lies below the nominal value. For D2 and D50, the width of
the acceptance band is dominated by the rD uncertainty sampling. The inﬂuence of
the rD uncertainty sampling on the DVMs is consistent between the pCT and the
BD-CTs, however shifted by the underlying diﬀerence of the DVMs between pCT
and BD-CTs. This observation is true for all other patients and structures.
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As an example for an OAR, ﬁgure 5.5 shows the DVM data for the bowel of the
previously showcased patient. The DDWE shows the largest diﬀerences for D2. The
Figure 5.5.: DVMs for the DDpCT and DDBD-CTs (circles) for the bowel for patient
MRG3. Set-up uncertainty sampling is shown as boxplots, the range of
the rD uncertainty sampling is shown as the errorbars. The absolute
dose is shown for one fraction.
width of the acceptance band is, similarly to the PTV, dominated by the rD un-
certainty sampling, and not by the set-up uncertainty sampling. For D15, however,
the set-up uncertainty sampling dominates. The relative DVM diﬀerences for all
BD-CTs lie within this acceptance band, including the rD uncertainty sampling of
the BD-CTs.
For the PTV, the acceptance band is met for the DD4t for all patients. For this
BD-CT, also the DVMs of the OARs lie within the acceptance band (or below, as
lower dose is never critical for OARs) for all investigated cases. The rD uncertainty
sampling, visualized as the errorbar, for DD4t slightly exceeds the acceptance bands,
however these ”tips” of errorbars which exceed the acceptance bands are worst case
scenarios of the rD uncertainty. Most of the errorbar range is within the acceptance
band.
For the DD2t, the acceptance ratio for the PTV drops, as two patients exceed the
acceptance band. For three patients, the D2 value for the bowel lies above the ac-
ceptance band.
For DD1t, all patients fail the PTV acceptance band criterion due to a general un-
derdosage. The acceptance ratio of the OARs is comparable to the one for DD2t:
two failures of DD1t for the bowel.
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DDWE fails the PTV criteria for two patients, for which also the OARs show over-
dosage with respect to the threshold.
The further the DVM value lies at the edge of the acceptance band, the more of
the rD uncertainty sampling range, i.e. the errorbar, lies outside of the acceptance
band. This is due to the comparable impact of rD uncertainty sampling on the
diﬀerent computed tomography (CT) images, shifted by the underlying diﬀerence
of the nominal DVM diﬀerence.
5.1.1. Discussion
BD values The standard deviation of the patient-speciﬁc mean rED values µ and
the separation thresholds are below 1 %. This could motivate the usage of cohort-
averaged rED values for the BD overwrite values, which in turn would be advan-
tageous in MR-only treatment planning, when no patient-speciﬁc information is
available. As the number of patients included in this study was low, more patient
data would are necessary for more signiﬁcant cohort results. Compared to White
et al. (2016), the average µfat is slightly smaller than the published value, which most
probably results from diﬀerences in the applied Hounsﬁeld look-up table (HLUT).
Comparison of the BD-CTs The analysis of GPRs in this study was performed for
the PTV. The gamma analysis is only partially suitable for OARs, since deviations
from reference dose are penalized in both directions. Underdosage is not critical
for an OAR, but this cannot be distinguished from critical overdosage in the GPR.
Thus, gamma analysis was only used for the target volume, where any deviation is
of disadvantage for the patient. The results show a clear dependency of the GPR
to the granularity of the BD-CT: while the BD-CTs with one BD (WE or 1t) can
have GPR down to almost 50 %, the GPRs for the BD-CT4t are at 100 % for all
patients.
In comparison to the GPR, the 3D cubes showing the gamma index for each voxel
are more meaningful to directly correlate the index to anatomy. The observations
linking, for example, cortical bone to shadows of gamma index failure are compre-
hensible based on the strong rD diﬀerences in these areas. Comparing the BD-CT2t
and BD-CT4t (and their gamma cubes) clearly shows the improvement in dosimetric
agreement due to the bone BD, as the shadows behind bone decrease signiﬁcantly.
The impact of the bone alone might be dominant, but it can not be distinguished
quantitatively from the imapct of the BD for air, which is also added in the BD-
CT4t. The absence of air in the BD-CTs is equivalent to the clinical situation, when
an intestinal gas bubble moves out of the beam path from the time of the pCT to the
actual time of the treatment. The opposite might also occur: a gas bubble moving
into the beam during treatment which was not present in the pCT. Both events are
currently taking into account by the PTV, to ensure clinical target volume (CTV)
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coverage. If the gas bubble is considered an indicator for movement of the bowel, it
might however be reasonable to include also a BD for air.
The results of the DVMs show the same tendencies of agreement with the pCT (BD-
CT4t better than BD-CT2t, better than BD-CTWE, better than BD-CT1t) as the
analysis of the mean rD in table 5.3. It might indicate that the standard deviation of
the rD diﬀerence is not as important as the mean, because both the mean diﬀerence
of the rD and the mean relative dose diﬀerences are comparable between the BD-
CT4t and the BD-CTWE, whereas the BD-CTWE has a larger standard deviation.
Even for the best performing BD-CT, BD-CT4t, the rD uncertainty sampling lead
to a slight exceeding of the acceptance bands at the tips of the errorbars. As for
the sampling only a general under- and overestimation of ± 1.5 % was assumed,
dedicated eﬀort should be invested in the determination of the BD overwrite values
to reduce this uncertainty. Possible options are improved imaging techniques, for
example dual-energy x-ray CT (DECT) imaging, or direct measurement of rED of
tissue. As this uncertainty is even more relevant for proton therapy, more details on
possible solutions can be found in the discussion in section 5.2.3.
Comparison to literature Eilertsen et al. (2008) presented relative dose diﬀerences
for the CTV, the bladder and the rectum for synthetic computed tomography (sCT)
images with a BD approach for ten prostate cancer patients. They achieved best
results for a sCT with one BD for bone equivalent to mass density 1.3 g/cm2,
and setting the remaining body to a water-equivalent (WE) BD. Averaged over all
patients, they found a relative diﬀerence of the mean dose of the CTV of 0.2 %,
and a relative diﬀerence of the maximum dose of the bladder of 4.1 %. Taking into
account that the CTV is less sensitive to dosimetric changes as it is ”shielded” by the
PTV, even the BD-CT2t shows comparably good results for the D50 as a substitute
for Dmean in table 5.3. The D2, as a substitute for maximum dose, for the urinary
bladder performs better than the sCT images in the same study. If you theoretically
add the uncertainty of the application of the MR image to the results of this study,
the BD-CT4t may be an adequate choice of BD overwrites for sCT images. The
BD-CT is hardly distinguishable from the pCT any more.
A more comparable study in terms of BD composition of the sCT images was pub-
lished by Tyagi et al. (2017) for prostate cancer patients. They performed a dosi-
metric evaluation of sCT images generated with a commercial software. The sCT
images contain ﬁve BD classes including air, fat, no-fatty soft tissue, soft bone and
hard bone. They reported median relative dose diﬀerences to the pCT images for
20 patients in the range of ± 0.5 % for all investigated structures. Comparing the
reported D95 and Dmax for the PTV to D98 and D2 in this study, the results are
in good agreement. The published results generally seem slightly better than in
this study (where relative dose diﬀerences of more than 0.5 % have occurred). For
the small and large bowel, they report the IQRs of the relative dose diﬀerences of
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the maximum dose to be within the -0.5 % to +0.5 % range. However, is it hard
to evaluate dosimetric changes if only the maximum dose to a structure is given.
The separation of bone into soft and hard bone in Tyagi et al. (2017) might be
responsible for the observed smaller dose diﬀerences therein.
Consequences for proton therapy The metrics used for analysis, i.e. the range
analysis, the GPR and gamma cubes, and the analysis of the DVHs, have shown
consistent results with complementary information. The predictive power of the
rD or range analysis, which could make full dose (re-)calculation redundant, should
be subject of future investigations. For now, the analysis metrics are considered
suitable for further investigations for proton therapy.
As proton beams are more susceptible to changes in rD, further separation of the
bone segments should be considered. One drawback of the presented approach of
granularity reduction in the CT image is, that it is not possible to directly quantify
the error of individual BD values. For example: the part of the error caused by the
single BD for bone is not distinguishable from the part caused by the other BDs.
Thus, it may help to identify the contribution of individual BD values investigating
BD-CTs with BDs and original content from the pCT.
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5.2. BD-CTs for proton therapy
Based on the gained knowledge and the developed workﬂow for the analysis of BD-
CTs for intensity-modulated radiotherapy (IMRT), the impact of BD-CTs on the
DD for intensity-modulated proton therapy (IMPT) is investigated in this section.
The investigation is split into two parts with two diﬀerent datasets: the Heidelberg
Ion-Beam Therapy Center (HIT) dataset, which contains clinical treatment plans
used as references, and the Gold Atlas dataset, for which also sCT images will be
created in the next section. The analysis of the histogram peak positions is followed
again by the analysis of the BD-CTs including range analysis, gamma analysis, and
DVH analysis. In the discussion, a set of recommended tissue classes for the sCT
images is presented.
5.2.1. HIT dataset
Histogram Analysis
The peak positions of the two-termed Gaussian function (cf. equation 4.4) ﬁtted to
the stopping power ratio (SPR) histogram, the threshold value, and the mean values
of the bone segments are summarized in table 5.4. For the analysis of the BD-CTs
for proton therapy, the bone segment was further split into soft and hard bone (cf.
section 4.5.1). The average value over all patients (± the standard deviation) for the
Table 5.4.: Peak positions µfat and µst of the two-termed Gaussian function ﬁtted to
the SPR histogram, representing fat and soft tissue (st). The minimum
between the two peaks is used as a threshold to separate those two classes.
The mean SPR values of the pre-segmented bone are given for the soft
bone, the hard bone, and all bone segments.
SPR µfat µst threshold soft bone hard bone all bone
HIT1 0.937 1.048 0.991 1.136 1.541 1.160
HIT2 0.926 1.029 0.987 1.133 1.519 1.157
HIT3 0.925 1.039 0.981 1.151 1.555 1.193
HIT4 0.935 1.032 0.982 1.157 1.520 1.203
HIT5 0.924 1.031 0.985 1.177 1.509 1.207
fat peak is 0.929 ± 0.005, for the soft tissue peak 1.036 ± 0.007, for the threshold
0.985 ± 0.004, for the soft bone segment 1.151 ± 0.016, to the hard bone segment
1.529 ± 0.017, and for all bone 1.184 ± 0.021.
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Range Analysis
The range analysis, as described in section 4.7, was performed comparing the dose
from the pCT and the BD-CTs. As the visualization of range diﬀerence maps for
every patient and beam would be beyond the scope of the thesis, ﬁgure 5.6 shows
the diﬀerence maps for patient HIT3 for the beam at 0° only. This patient shows
the largest diﬀerences and variations among the cohort. Subﬁgure (a) clearly shows
(a) pCT - BD-CTWE (b) pCT - BD-CTB1
(c) pCT - BD-CTSTB1
(d) pCT - BD-CTST (e) pCT - BD-CTB2 (f) pCT - BD-CTSTB2
Figure 5.6.: Two-dimensional plots of the pencil-beam-wise range diﬀerences be-
tween the pCT and (a) BD-CTWE, (b) BD-CTB1, (c) BD-CTSTB1, (d)
BD-CTST, (e) BD-CTB2, and (f) BD-CTSTB2.
the overshoot of the proton beams using a WE BD-CT. In subﬁgure (d), the overall
diﬀerence for BD-CTST is much smaller, though a slowly varying diﬀerence can
be seen. BD-CTB1 in subﬁgure (b) creates larger range diﬀerences as compared
to BD-CTB2 in subﬁgure (e). Those diﬀerences are enhanced for BD-CTSTB1 in
subﬁgure (c) and BD-CTSTB2 in subﬁgure (f), which behave like sums of BD-CTST
and BD-CTB1/B2.
The pencil-beam-wise absolute range diﬀerences are averaged for each patient, the
results are summarized in table 5.5. Largest absolute diﬀerences and standard de-
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Table 5.5.: Mean and standard deviation (sd) of the absolute range diﬀerence be-
tween the pCT and the BD-CTs (cf. table 4.3) for all pencil-beams of
the treatment plan for the ﬁve patients of the HIT dataset. The average
over all patients is shown in the last row.
patient mean (sd) absolute range diﬀerence [mm]
WE ST B1 B2 STB1 STB2
HIT1 11.5 (6.1) 2.7 (1.3) 1.7 (1.6) 1.5 (1.1) 3.0 (1.8) 2.4 (1.6)
HIT2 3.5 (2.5) 0.6 (0.8) 1.0 (1.4) 0.7 (1.2) 1.5 (1.5) 1.4 (1.4)
HIT3 8.2 (4.1) 1.9 (1.2) 1.7 (1.4) 0.8 (0.8) 3.2 (2.1) 2.3 (1.5)
HIT4 12.3 (4.5) 1.2 (0.9) 2.0 (1.6) 1.1 (0.9) 2.8 (1.8) 1.6 (1.1)
HIT5 7.3 (3.7) 0.7 (0.6) 1.5 (1.2) 0.9 (0.7) 1.9 (1.4) 1.4 (1.1)
average 8.6 (4.2) 1.5 (0.9) 1.6 (1.4) 1.0 (1.0) 2.5 (1.7) 1.8 (1.4)
viations among the BD-CTs are observed for the BD-CTWE for all patients. Going
from one BD for bone to two BD, an improvement, i.e. a decrease in diﬀerence,
can be observed for all patients. Also the standard deviations decrease, which in-
dicates more reliable results. The absolute diﬀerence in rD for BD-CTST ranges
from 0.6 mm to 2.7 mm. The larger the diﬀerence for this BD-CT, the larger also
the absolute diﬀerence for BD-CTSTB1 and BD-CTSTB2, respectively. This is due
to the combinatory eﬀect of the BDs. Large variations among the patients can be
observed, most prominently for the BD-CTWE, but with similar trends also for the
other BD-CTs.
Gamma Analysis
Gamma analysis was performed comparing the DDpCT to DDBD-CTs. Examples of
two 2D slices of the gamma cube comparing DDpCT and DDST for one patient
are shown in ﬁgure 5.7. In both examples it becomes clear from the ﬁgure, that
the failures of the gamma criterion mostly occur just outside of the PTV, which
corresponds to the end of the proton ranges of the beams. This is the case for all BD-
CTs, however local ”hotspots” of GPR failure can be observed at various positions.
For the DDB1, hotspots can be observed after signiﬁcant passages through hard bone
(results not shown). The GPR failure in ﬁgure 5.7 is present in all BD-CTs with
soft tissue BDs.
The GPRs were evaluated for the PTV only. The results of the gamma analysis for
all patients are summarized in ﬁgure 5.8. The DDWE shows the lowest GPRs for
all patients, visible from the errorbar. The GPRs for the DDB2 are closer to the
optimal 100 % than for DDB1 for all patients. For the DDSTB1 and DDSTB2, the
GPRs show larger deviations due to the combinatory eﬀect of the BDs. The worst
GPR for the DDSTB2 of 97.6 % was observed for patient HIT1.
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Figure 5.7.: Two-dimensional examples of the gamma analysis performed using a
2mm/2% criteria for DDST of patient HIT3 overlaid onto the corre-
sponding CT slices. On top, a slice through the urinary bladder at the
edge of the CTV is shown, which is the source of GPR failures left and
right to the bladder. At the bottom, a slice through the target volume
is shown.
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Figure 5.8.: Mean gamma pass rates (GPRs) using a 2mm/2% criterion for the PTV
of DDBD-CT (dots) for the HIT dataset. The ranges (minimum to max-
imum GPRs) are shown as errorbars.
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Table 5.6.: Mean relative dose diﬀerence and standard deviation (sd) of the ﬁve patients of the HIT dataset for the diﬀerent
DDBD-CTs.
mean (sd) relative DVM diﬀerences [%]
DVM WE ST B1 B2 STB1 STB2
PTV
D2 -0.08 (1.13) 0.03 (0.08) 0.04 (0.09) 0.03 (0.10) -0.02 (0.06) -0.01 (0.06)
D50 -0.88 (0.36) -0.02 (0.04) 0.00 (0.03) -0.04 (0.10) 0.03 (0.15) 0.01 (0.06)
D98 2.43 (13.68) -1.57 (2.59) -0.88 (1.83) -2.27 (4.13) -1.10 (1.72) -1.56 (1.27)
urinary bladder
Dmax 0.30 (2.00) 0.42 (0.37) -0.03 (0.05) -0.02 (0.09) 0.06 (0.27) 0.07 (0.24)
D15 3.86 (10.24) -4.97 (4.69) 0.49 (1.52) -0.25 (3.10) -3.47 (3.60) -2.33 (2.54)
rectum
Dmax 1.01 (1.22) 1.07 (1.50) 0.53 (0.62) 0.56 (1.24) 1.07 (1.22) 0.81 (1.00)
D15 1.34 (4.50) 0.66 (0.54) 0.05 (0.27) 0.29 (0.34) 0.57 (0.48) 0.50 (0.47)
RPW
Dmax 34.57 (55.59) -2.28 (3.49) 1.26 (3.28) 1.29 (3.26) -2.64 (3.25) -2.46 (3.23)
D15 9.37 (6.72) -0.39 (1.26) 0.55 (1.24) -0.09 (0.36) 0.31 (2.19) -0.18 (1.71)
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Dose Volume Histogram Analysis
For the HIT dataset, the PTV and the most important OARs used for dose con-
straints during plan optimization, including the urinary bladder, the rectum and
the rectal posterior wall (RPW), have been analysed. The mean relative diﬀerences
of the DVMs of the ﬁve patients are summarized in table 5.6 with the standard
deviation in brackets. In proton treatment planning for prostate cancer, Dmax is
used as a dose constraint for the urinary bladder and the rectum. In both cases,
it should not exceed the prescribed dose (i.e. Dmax < 100 %). For this reason,
D2 was replaced with Dmax from here on for the analysis of the OARs. For the
RPW, V50Gy(RBE) < 17 % and the V32Gy(RBE) < 35 %, i.e. the partial volume of
the structure that receives 50 Gy(RBE), and 32 Gy(RBE), respectively, are used
as constraints during plan optimization. However, in all cases in this study, the
V50Gy(RBE) and the V32Gy(RBE) are well below 1 % and thus are not reported explic-
itly. For the PTV, the largest deviations from the reference DD were observed for
the D98. A negative D98 diﬀerence, as observed for DDST, DDB1, DDB2, DDSTB1,
and DDSTB2, indicates a worse target coverage. Surprisingly, DDB2 shows even
worse target coverage than DDB1. In addition, the variation among the patients is
also larger, indicated by larger standard deviations. Similar trends are also present
among the OAR DVMs.
DDWE shows the largest dose diﬀerences for the RPW of up to 34.57 % for Dmax.
At the same time, Dmax of the pCT is much smaller (between 0.5 Gy(RBE) and
1 Gy(RBE)) for the RPW than for the bladder or the rectum, leading to larger
relative diﬀerences. For the other structures, DDWE does not show signiﬁcantly
larger diﬀerences in comparison to the other DDs.
Dmax increases for the urinary bladder and the rectum, which might hint towards a
exceeding of the dose constraints. For the RPW, Dmax decreases with respect to the
reference DD for most patients, dominated by the strong impact of the soft tissue
BDs.
Figure 5.9 shows the DVMs for the PTV for patient HIT5 as an example. The
relative dose diﬀerences of all BD-CTs are below 0.5 % for the shown DVMs. Even
for BD-CTWE, which shows the largest deviations, the deviations are smaller than
0.5 %. The deviations can thus be considered negligible.
The acceptance bands are inﬂuenced both by the rD and the set-up uncertainty
sampling. Only for D98, a clear dominance of the set-up uncertainty sampling is
observable. BD-CTWE exceeds the acceptance bands for D2 and D50. For D98, also
exceedings of the other BD-CTs can be observed in the order of 0.1 percent points.
However, as the overall deviations are so small, these deviations are still negligible.
The errorbars of the BD-CTs, representing the rD uncertainty sampling for these
images, also lie within the acceptance bands for most parts. The tips of the errorbars,
however, might exceed the acceptance bands slightly, even though the nominal DVM
values lies well within the acceptance band.
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Figure 5.9.: DVMs for the pCT and BD-CTs for the PTV for patient HIT5.
For the remaining patients not shown here, the results for the analysis of D2 and
D5 are similar and the relative dose diﬀerences are small (below 0.5 %, except for
BD-CTWE). Only for D98, larger deviations occur.
Similarly to the showcased patient, several other patients show exceedings of the
acceptance bands, however the deviations are still small enough in all cases to be
considered negligible. D98 is less aﬀected by acceptance band exceedings, as the set-
up uncertainty sampling can lead to deviations up to 30 percent points. BD-CTWE
shows exceedings of the PTV acceptance bands for patients HIT1, HIT2, and HIT3.
While the impact of the rD uncertainty sampling between the pCT and the BD-CTs
is comparable in width to the shown example, for other patients more variation
can occur. This also impacts the overlap between the acceptance bands and the
errorbars.
A corresponding plot is shown for the urinary bladder in ﬁgure 5.10 also for patient
HIT5. The relative deviations of the BD-CTs are well below 1 % for D15 and even
below 0.5 % for Dmax. An increase in dose is observed for DDST, DDSTB1, and
DDSTB2 to a maximum of approximately 0.4 %. All DVMs, however, lie within the
acceptance bands.
For Dmax, the rD uncertainty sampling dominates the width of the acceptance band,
for D15 it is the set-up uncertainty sampling. Only minor exceedings of the BD-CT
errorbars can be observed for Dmax.
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Figure 5.10.: DVMs for DDpCT and DDBD-CTs (circles) for the urinary bladder for
patient HIT5. Set-up uncertainty sampling is shown as boxplots, the
rD uncertainty sampling is shown as errorbars.
For the other patients, most exceedings of the acceptance bands were observed for
BD-CTWE for at least one OAR for patient HIT1, HIT2, and HIT3. A critical
exceeding of the acceptance band was observed for patient HIT1 for DDST for Dmax
of the urinary bladder, and for DDST and DDSTB1 for Dmax of the rectum. For all
other OARs and DVMs, deviations are well below 1 %. Larger deviations above 1 %
occur, but are within the acceptance band.
Exemplary insertion of a BD for the urinary bladder
In the gamma analysis for the DDST shown in ﬁgure 5.7, it is clearly visible, that
the urinary bladder has a strong impact on the DD. It is diﬃcult to quantify, how
much of the dose diﬀerences seen for DDST is due to the BD for fat and the non-fatty
soft tissue, and how much is due to the wrong overwrite of the BD in the bladder.
Thus, for one patient (HIT3), the urinary bladder was manually overwritten with a
BD value equivalent to the mean SPR value inside the delineated bladder (SPR =
0.9995). The grey values of the bladder lie on the left slope of the soft tissue peak
(compare to ﬁgure 4.5 or 4.6) and purely grey value based segmentation in the image
is not possible. Thus, the delineated urinary bladder included in the patient dataset
68 Chapter 5 Results
was used to overwrite the bladder volume with a BD value. The BD-CT created in
this way is referred to as BD-CTST+bladder, the re-calculated dose as DDST+bladder,
respectively.
The range diﬀerence improved from 1.9 mm to 1.5 mm for the mean absolute dif-
ference, and from 1.2 mm to 0.8 mm for the standard deviation of the absolute
diﬀerence.
The GPR for the PTV increased from 98.4 % to 99.2 %. Figure 5.11 shows the
respective slice of the gamma analysis of DDST+bladder as in ﬁgure 5.7. The gamma
Figure 5.11.: Two-dimensional example of the gamma analysis performed using a
2mm/2% criteria for DDSTbladder of patient HIT3 overlaid onto the
corresponding CT slice. The same slice is shown as in ﬁgure 5.7.
value hotspots that were created at the distal ends of beams passing through the
bladder are not present any more. The improvement in the GPR is also reﬂected in
the improvement of the relative diﬀerences of the DVMs comparing DDST and the
new DDST+bladder in table 5.7. For all DVMs, the relative diﬀerence decreases. The
only exception is D15 for the RPW, which slightly increases from 0.13 % to 0.35 %,
and can thus still be considered acceptable. Especially for the urinary bladder itself,
strong improvement is observed: D15 improves from -7 % to 1 %.
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Table 5.7.: Relative DVM diﬀerences for DDST and DDST+bladder for patient HIT3.
relative DVM diﬀerence [%]
DVM ST ST+bladder
PTV
D2 0.17 -0.09
D50 -0.05 -0.03
D98 -5.66 -2.21
urinary bladder
Dmax 0.56 -0.12
D15 -7.14 0.71
rectum
Dmax 3.66 0.66
D15 0.76 -0.11
RPW
Dmax -6.59 -4.04
D15 0.13 0.35
5.2.2. Gold Atlas dataset
As the HIT dataset only contained 5 patients, among which one was a cervix cancer
patient and the others where prostate cancer patients, the results are not particularly
signiﬁcant. In contrast, the Gold Atlas dataset contains 19 patients, for which
prostate cancer treatment plans have been optimized.
Histogram Analysis
All pCT images from the Gold Atlas dataset have been translated to SPR images
using a clinical HLUT, since no clinical HLUTs calibrated for the respective CT
scanners have been delivered with the image data. However, no bias is expected
from using this HLUT, since the pCT as the gold standard is also translated to SPR
using the same HLUT for dose calculation. To account for the diﬀerent scanners,
the BD SPR values derived from the Gaussian ﬁt and the averaging over the bone
structures are averaged over the patients of each site. The results are shown in
table 5.8.
Table 5.8.: Mean SPR values for the patients of the Gold Atlas dataset. Mean values
are shown for each site (GA1-3) and for all patients.
SPR µfat µST threshold soft bone hard bone all bone
GA1.1-8 0.956 1.031 0.996 1.136 1.478 1.159
GA2.1-7 0.943 1.022 0.991 1.138 1.514 1.174
GA3.1-4 0.957 1.041 0.997 1.139 1.478 1.163
Diﬀerences between the diﬀerent sites are less pronounced between GA1 and GA3,
whereas GA2 shows larger diﬀerences compared to the former two. The mean value
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of all patients (± the standard deviation) for the fat peak is 0.951 ± 0.008. For the
soft tissue peak it is 1.030 ± 0.009, for the threshold it is 0.994 ± 0.003, for the soft
bone segment it is 1.138 ± 0.010, for the hard bone segment it is 1.491 ± 0.026, and
for all bone it is 1.165 ± 0.016.
Range Analysis
The analysis of the pencil-beam-wise absolute range diﬀerence between the pCT
and the BD-CTs averaged over all 19 patients is shown in table 5.9. Comparing the
Table 5.9.: Mean and standard deviation (sd) of the absolute diﬀerence in range
between BD-CTs and pCT for all pencil-beams of the treatment plan for
the 19 patients of the Gold Atlas dataset, averaged per site and over all
patients (bottom row).
site mean (sd) absolute range diﬀerence [mm]
WE ST B1 B2 STB1 STB2
GA1.1-8 10.7 (2.8) 0.9 (0.8) 1.7 (1.9) 1.1 (1.3) 2.0 (2.3) 1.4 (1.5)
GA2.1-7 9.5 (3.8) 0.8 (0.9) 2.2 (2.4) 1.1 (1.3) 2.1 (2.6) 1.3 (1.7)
GA3-1.4 10.7 (2.7) 0.6 (0.7) 1.9 (1.9) 1.1 (1.2) 2.1 (2.2) 1.3 (1.4)
average 10.3 (3.1) 0.80 (0.8) 1.9 (2.1) 1.1 (1.3) 2.1 (2.4) 1.3 (1.6)
results for the BD-CTST, BD-CTB1 and BD-CTB2, the impact of the soft tissue BD
on the absolute range diﬀerence is always smaller than the impact of the bone BD
values. This is in contrast to the observations with the HIT dataset, where the soft
tissue BDs had a comparable or even stronger impact on the diﬀerence. The overall
mean absolute diﬀerences for the BD-CTSTB1 and BD-CTSTB2 are smaller than for
the HIT dataset, where averaged over all patients the mean diﬀerences were 2.5 mm
and 1.8 mm for the two BD-CTs, respectively.
Figure 5.12 shows exemplary range diﬀerence plots for patient GA3.3, which shows
the largest mean absolute range diﬀerences for the BD-CTB1 and BD-CTB2 among
all patients of the dataset, and consequently also very large mean absolute diﬀerences
for the BD-CTSTB1 and BD-CTSTB2.
In subﬁgure (a), the same overshooting of the proton beams can be observed as for
the BD-CTWE for the HIT dataset. As the mean absolute range diﬀerence averaged
over the patient cohort already suggested, the diﬀerence plot shown in subﬁgure (d)
for BD-CTST shows only minor variations. The central negative range diﬀerence in
subﬁgure (b) for BD-CTB1 (corresponding to an undershooting of the proton beam)
and the overshoot in the lower left corner smooth out for BD-CTB2 in subﬁgure
(e). Subﬁgures (c) and (f) are visually almost indistinguishable from (b) and (c),
respectively, due to the negligible impact of the soft tissue BD compared to the bone
BDs.
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(a) pCT - BD-CTWE
(b) pCT - BD-CTB1
(c) pCT - BD-CTSTB1
(d) pCT - BD-CTST (e) pCT - BD-CTB2 (f) pCT - BD-CTSTB2
Figure 5.12.: Two-dimensional plots of the pencil-beam-wise range diﬀerences be-
tween the pCT and the BD-CTs for patient GA3.3 and the beam at
0°.
Gamma Analysis
Figure 5.13 shows the mean GPRs for the PTV for all 19 patients of the Gold Atlas
dataset. The errorbar again represents the range of GPRs observed among those
patients. Similar to the observations with the HIT dataset, the DDWE shows the
lowest GPRs among the BD-CTs. For the DDST, no gamma index failure can be
observed, leading to GPRs of 100 % for all patients. The improvement in GPR going
from DDB1 to DDB2, and from DDSTB1 to DDSTB2, is represented by the increase
mean GPR and the decrease in range of GPRs. The smallest GPR for the DDSTB2
is 97.1 % for patient GA1.3.
The analysis of the 3D gamma cubes indicates two possible reasons for failures of
the DDST, which are, however, outside of the PTV. First, metallic markers in the
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Figure 5.13.: Mean gamma pass rates (GPRs) using a 2mm/2% criterion for the
PTV of DDBD-CT (dots) for the HIT dataset. The ranges (minimum
to maximum GPRs) are shown as errorbars.
CT image occurred for two patients of GA1 and two patients of site GA3. In this
case, the SPR is overwritten with soft tissue BD values. Second, contrast agent in
the urine that settles at the posterior side of the bladder and thus close to the target
volume was also observed. The contrast agent increases the SPR of the urine, but
is overwritten with a soft tissue BD as well. This occurred for ﬁve out of seven
patients for site GA2. An example of a 2D slice of the pCT and the corresponding
failure of the gamma values for the DDST is shown in ﬁgure 5.14.
For the DDB1, at all passages of the beam through hard bone, failures occur in the
3D gamma cube (results not shown). Those are considerably reduced for the DDB2.
However, also within the BD-CTB2, cortical bone might not be well represented at
all times, which leads to smaller ”hotspots” of gamma values in the 3D cubes.
Dose Volume Histogram Analysis
The diﬀerences of the DVMs for the DDBD-CTs in the PTV, the urinary bladder,
the RPW and the rectum relative to the DDpCT are summarized for all patients
in table 5.10. Similar to all metrics and datasets analysed before, DDWE yields
the largest, unacceptable deviations for all structures and it is therefore not further
discussed. DDST shows almost no deviations for the analysed DVMs and structures.
The largest deviation is observed for D15 for the urinary bladder with (1.03 ±
4.15) %, which, however, does not exceed clinical constraints in any investigated
case. Due to the almost negligible impact of the soft tissue BDs, the DDs of the
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Figure 5.14.: Two-dimensional example of the gamma analysis performed using
2mm/2% criteria for DDST of patient GA2.5 overlaid onto the cor-
responding CT slice. For better visualization of the contrast agent
settlement in the urinary bladder, this image section is zoomed in.
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Table 5.10.: Mean relative dose diﬀerence and standard deviation (sd) of the 19 patients of the Gold Atlas dataset for the diﬀerent
DDBD-CTs.
mean (sd) relative DVM diﬀerences [%]
DVM WE ST B1 B2 STB1 STB2
PTV
D2 -0.52 (0.31) 0.02 (0.04) -0.05 (0.08) 0.00 (0.04) -0.02 (0.10) 0.02 (0.06)
D50 -0.66 (0.34) 0.06 (0.07) -0.17 (0.07) -0.05 (0.08) -0.10 (0.10) -0.01 (0.09)
D98 0.46 (1.29) 0.19 (0.57) -4.63 (2.91) -1.20 (1.55) -4.14 (3.23) -1.27 (1.62)
urinary bladder
Dmax 1.00 (1.37) 0.09 (0.22) 0.20 (0.71) 0.28 (0.63) 0.22 (0.75) 0.25 (0.59)
D15 9.97 (5.61) 1.03 (4.15) -2.88 (1.17) -0.54 (1.07) -1.55 (4.30) 0.54 (4.32)
rectum
Dmax 2.24 (1.05) 0.05 (0.13) 0.28 (0.51) 0.13 (0.40) 0.28 (0.54) 0.18 (0.40)
D15 -3.17 (4.02) -0.28 (0.57) -0.33 (1.07) -0.30 (0.85) -0.78 (1.21) -0.66 (1.04)
RPW
Dmax 4.98 (4.98) 0.05 (0.59) 0.18 (1.13) 0.30 (1.14) 0.08 (1.06) 0.23 (1.27)
D15 -2.92 (3.33) -0.19 (0.58) -0.75 (2.55) -0.24 (1.45) -0.88 (2.61) -0.61 (1.32)
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combined BDs for soft tissue and bone (DDSTB1 and DDSTB2) are dominated by the
diﬀerences observed for the DDB1 and DDB2.
The PTV is not covered adequately with dose for DDB1 and DDSTB1, as can be
seen by the mean decrease of D98 of more than 4 %. This DVM and the D15 for the
urinary bladder show the most signiﬁcant improvements when going from DDB1/STB1
to DDB2/STB2. For most OARs, Dmax slightly increases (maximum of 0.28 %) and
D15 decreases (maximum of 2.88 %). Generally speaking, the diﬀerences are quite
small, with only few DVMs exceeding a 1 %-diﬀerence.
Patient GA2.6 was the only patient who showed a failure of the acceptance band
criterion for an OAR. Thus, for this patient, the DVMs for the PTV and the uri-
nary bladder are shown in ﬁgures 5.15 and 5.16, respectively. For the PTV, the
observed relative diﬀerences to DDpCT for the D2 and D50 are small (below 0.5 %),
in agreement with the mean values in table 5.10. For D98, the relative diﬀerences
are larger, up to approximately 5 % for DDB1, however all diﬀerences are covered by
the acceptance band. As for the HIT dataset, the width of the acceptance band for
D98 is dominated by the set-up uncertainty sampling. The errorbars, representing
the rD uncertainty sampling, show diﬀerent behaviour for each BD-CT compared
to the pCT. For the PTV, the largest parts of the rD uncertainty sampling are also
covered by the acceptance bands.
For the remaining 18 patients Gold Atlas dataset, the situation is similar as for the
shown example: for D2 and D50, all DVM diﬀerences are below 0.2 %, and for D98
larger deviations occur, but are covered by the acceptance band without exceptions.
For the urinary bladder, the showcased patient in ﬁgure 5.16 is the only case, where
critical exceeding of the acceptance band occurs. Although the clinical constraint
Dmax < 100 % is exceeded for four patients, patient GA2.6 is the only case where also
the acceptance band is exceeded. The exceeding of the clinical constraint occurred
only for patients, where the Dmax of DDpCT was very close to 2.7 Gy(RBE), i.e.
100 % of the prescribed dose per fraction, as shown in the ﬁgure.
For the OARs, the width of the acceptance band is mostly deﬁned by the IQR of the
shift uncertainty sampling, since the investigated OARs are not located around the
distal ends of the proton beams. For the D15, the acceptance bands thus also fully
cover the errorbars of the BD-CTs. For the Dmax for the urinary bladder, only BD-
CTST and BD-CTSTB2 in ﬁgure 5.16 are fully covered. The approximate widths of
the acceptance bands are comparable in size to the widths of the acceptance bands
for the HIT dataset. This can be seen for example for the ﬁgures 5.15 and 5.16.
This hints towards comparable treatment plans in terms of intrinsic robustness, as
the basic boundary conditions (i.e. the prescribed dose and dose constraints) are
fulﬁlled by all plans.
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Figure 5.15.: DVMs for the pCT and BD-CTs for the PTV for patient GA2.6.
5.2.3. Discussion
BD values Generally, the comparison of Hounsﬁeld unit (HU) values to literature
HU values is more reasonable, as those are not biased by the applied HLUT. The
analysis of the SPR values, on the other hand, allows comparison to methods that
directly measure the SPR, for example proton radiographies (Schneider and Pedroni,
1995) and tomographies (Schulte et al., 2004). However, no such techniques are
clinically available yet mostly due to technical reasons. Instead, only phantom
measurements have been performed so far. Technically already possible is the usage
of DECT images, from which SPR information can be derived (Wohlfahrt et al.,
2017). SPR from DECT images is the closest to a ground truth achievable at
the moment. DECT-derived SPR image would currently be the best reference for
synthetic SPR images derived from MR. Unfortunately, no DECT image dataset or
even a DECT with corresponding MR image dataset was available for this study. In
anticipation of such data, the investigation in this thesis used SPR values instead of
HU. The methods and the analysis procedure presented here are, therefore, suitable
for future investigations, when MR and DECT data becomes available.
More conﬁdence in the BD SPR values would in turn lead to a smaller uncertainty
range from the rD uncertainty sampling. In this thesis, ± 1.5 % was assumed as SPR
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Figure 5.16.: DVMs for the pCT and BD-CTs for the urinary bladder for patient
GA2.6.
or rD uncertainty, which is already a smaller uncertainty than presented in Paganetti
(2012) for the combined uncertainties related to CT and HU-to-SPR conversion.
Thus, with a smaller range of rD uncertainties, the remaining risk of exceeding the
acceptance band would shrink to a minimum. The acceptance band, however, might
shrink correspondingly where the rD uncertainty sampling has stronger impact than
the set-up uncertainty sampling (e.g. for the PTV).
The comparison of the BD overwrite values derived from the SPR histogram shows
some diﬀerences between the HIT and the Gold Atlas datasets: the fat BD value and
the threshold are smaller for the HIT dataset than for the Gold Atlas, whereas for the
three BD values for bone the opposite is the case. The most obvious explanation
for this is the applied HLUT, that diﬀered between the two datasets. It should,
however, not be problematic for the investigation, as the BD values were derived
from the SPR histogram instead of the HU histogram. This overcomes the bias of
the applied HLUT relative to the pCT.
BD-CTWE The application of BD-CTWE is not recommended based on the poor
performance of all the analysed metrics. Mean absolute range diﬀerences of more
than 10 mm were observed for two HIT patients and nearly all Gold Atlas patients.
The GPRs of the PTV drop down to almost 74 % and the DVM exceed the majority
of acceptance bands. These ﬁndings are in agreement with Koivula et al. (2016),
where the GPR of the WE sCT image was 86.8 % with a 2mm/2% criterion for the
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volume where the dose is above 10 % of prescribed dose. It should be mentioned
that this volume is larger than the PTV, which might explain the diﬀerence between
the publishe GPR and the GPR observed here.
Comparison of BD-CTs The BD-CTST, BD-CTB1, and BD-CTB2 have been intro-
duced to analyse the inﬂuence of diﬀerent BD simpliﬁcations of the pCT individually.
The BD-CTST shows the worst results in all analysis metrics for the HIT dataset.
Not surprisingly, that these faults propagate to the combined BD-CTs (BD-CTSTB1
and BD-CTSTB2). For the Gold Atlas dataset, the BD-CTST performed signiﬁcantly
better for all metrics, and, consequently, the BD-CTSTB1 and BD-CTSTB2 also per-
form better.
The source of faults of the BD-CTST in the HIT dataset might be suboptimal choice
of BD overwrite values. For example, the µST is inﬂuenced by organs that are
not in the beam path, thus over-representing the corresponding SPR values and
under-representing the SPR values of organs in the beam path. The soft tissue
value should, theoretically, be more impaired by this, as most organs and soft tissue
structures fall into this tissue class and are well-distinguishable from fat. However,
when just comparing the SPR values, the fat SPR value seems more reasonable to be
the source of dose diﬀerences than the soft tissue SPR value. The most reasonable
explanation for the fault of the fat BD values might indeed be caused by the HLUT,
but not the HLUT itself: if the peak of the fat HU values is Gaussian and a HLUT
is applied, the peak might be skewed to one side. The peak position of the ﬁtted
Gaussian will then be slightly oﬀ.
The results obtained with the Gold Atlas dataset might be less sensitive by the
speciﬁc choice of BD overwrite values, because the volumes of the PTV are much
smaller and thus also the overall volume that the beams have to pass to reach the tu-
mour. For comparison, the mean PTV volume of the HIT dataset is approximately
260 cm3, for the Gold Atlas dataset it is 67 cm3. The lack of a clinically contoured
CTV as the basis for the PTV margin in the Gold Atlas dataset lead to this volume
diﬀerence.
The most prominent problem of the BD-CTST in the Gold Atlas dataset was the
presence of a contrast agent. Its impact was mostly visible in the gamma cubes. At
HIT, contrast agent is never applied for the acquisition of the pCT images, as iodine
has a high atomic number and, thus, a high SPR. During the treatment, no contrast
agent will be present and it would thus distort the planned DD signiﬁcantly. Nyholm
et al. (2018) state that the CT images in the Gold Atlas dataset were ”acquired as
part of clinical routine for treatment planning purposes”. However, no information
on the application of contrast agents and its purpose is given. This may explain the
observed results for the BD-CTST (without contrast agent) and the pCT (with con-
trast agent) for the Gold Atlas patients. Therefore, even better agreement between
DDpCT and DDST can be expected for pCT images without contrast agent.
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BD for urinary bladder An exemplary improvement of the BD-CTST could be
shown for patient HIT3 by adding a BD overwrite value for the urinary bladder.
The source of the failure is the presence of urine in the urinary bladder, which is
very similar to water. The threshold, however, classiﬁes it as soft tissue, leading
to a large diﬀerence in SPR in these voxels, which in turn leads to a large range
diﬀerence whenever the beam passes the bladder. As the PTV volume in the Gold
Atlas dataset is smaller, the beams hardly pass the urinary bladder. This explains
why the negative eﬀect of the urinary bladder seen for HIT patients was not observed
in the 3D gamma cubes for the DDST for the Gold Atlas patients.
With regard to the MR images and the generation of sCT images from it, the
bladder is not easily segmentable using grey value thresholds or probability masks
as for bone. The reason is that the grey value in the MR is might not be unique
for urine (depending on the sequence), and that the ﬁlling state can change the
position and shape of the bladder dramatically. With an appropriate MR sequence
or an advanced machine learning approach for sCT generation, a BD value for the
bladder is feasible and, from the example shown here, also advisable, if the proton
beam passes a considerable volume of the bladder.
BDs for bone The standard deviation of the BD values for bone are in the range of
0.010 and 0.026, which is quite large compared to the standard deviation of the soft
tissue BD values. This indicates a large variability among the patients, which will
become more important once cohort values will be applied. The glsBD values might
be inﬂuenced by the segmentation method applied in this study. This was, however,
consistently applied for all patients, thus the reason for the large standard deviation
might be rather a biological variation in bone density between the patients. Larger
cohorts need to be evaluated for more signiﬁcant conclusions.
The results of the mean absolute range diﬀerence and the gamma analysis for BD-
CTB1 and BD-CTB2 show no clear better option of the two, although the range
diﬀerence plots indicate that BD-CTB2 might be the preferable solution. In the
analysis of the DVMs, an improvement when going from BD-CTB1 to BD-CTB2
can be observed. It should be mentioned at this point, that a positive bias in the
results of the images might be due to the usage of the pencil-beam algorithm (cf.
section 2.3.2) for dose calculation. Vanderstraeten et al. (2007) performed a similar
analysis investigating the number of tissue bins required for accurate Monte Carlo
dose calculation. They recommend ten bins, i.e. ten BD values for bone. A further
splitting of bone into smaller subsets with one BD each is feasible and can be ex-
pected to further improve the results also with the pencil-beam algorithm. However,
it is more a diligent but routine piece of work to perform the BD-CT analysis for
these BD-CTs. At this point, the interest rather increases in the question, how these
BD values perform, when they are derived from an MR image.
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Comparison of the two datasets Disregarding the diﬀerences for the BD-CTST,
the results obtained with the HIT dataset and the Gold Atlas dataset are very sim-
ilar. The order of magnitude of the acceptance bands is comparable. However, the
impact of the rD and the set-up uncertainty sampling diﬀers between the datasets.
For the D98 of the PTV, for example, the set-up sampling dominates the acceptance
band, whereas for the Gold Atlas also the rD sampling has a signiﬁcant impact. The
D98 generally decreases for the Gold Atlas patients. Thus, the IQR lies below the
nominal D98. For the HIT dataset, the IQR spans around the nominal value. Two
possible reasons might be the size of the PTV (where the large PTV makes it more
robust against set-up errors) or the optimization itself being more robust to those
errors.
The improved acceptance rate of the DVM values for the Gold Atlas might as well be
due to the smaller volume. For both datasets, BD-CTSTB2 shows the better results
of the two full-BD-CTs (BD-CTSTB1 and BD-CTSTB2). The overall relative dose
diﬀerences are below 1 % and only for a few cases, the acceptance band is exceeded.
Thus, the BD content of BD-CTSTB2, namely, air, fat, non-fatty soft tissue, soft
bone and hard bone, will be the set of tissue classes, used to generate sCT images
from MR images in the next step.
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5.3. sCT from MR
This last section of the results summarizes the analysis results of the sCT images,
that have been created as described in section 4.5.3 using the previously developed
workﬂow for BD-CTs and the previously investigated set of BDs for air, fat, non-
fatty soft tissue, soft bone, and hard bone. The results will also be compared to
the BD-CT results, to identify the largest source of uncertainties and potential for
improvement. The MR images from the Gold Atlas dataset have been modiﬁed to
overcome the eﬀect of the bias ﬁeld (cf. section 2.1.2), they have been deformably
registered to the CT images to analyse the impact of anatomical diﬀerences or
distortions, and the two corrections of the MR images have been combined. In
total, the original MR image and three corrected versions of the MR image (i.e.
four in total) have been used to create four sCT images, respectively. As references,
they are compared against the pCT and against the BD-CTSTB2.
The basis for the sCT images were the T1-weighted MR images from the Gold Atlas
dataset. Only the images from the 12 patients of site 1 and 3 were used, as the MR
images are more comparable to each other in terms of the applied MR sequence. The
metrics analysis for the DDSTB2 has been added to the results as well for those 12
patients only and might thus diﬀer from the metric values presented in the section
above, where all 19 patients were analysed.
5.3.1. Range Analysis
The mean absolute range diﬀerence between the pCT and the BD-CTSTB2, sCTO,
sCTB, sCTR, and sCTBR, respectively, are summarized in table 5.11. It should be
mentioned that the range analysis is independent from the structure delineations,
as it only considers the pencil-beam positions planned for the PTV of the pCT.
Table 5.11.: Mean and standard deviation (sd) of the absolute diﬀerence in radiolog-
ical depth between BD-CTSTB2, the sCTs, and the pCT for all pencil-
beams of the treatment plan for the 12 patients of the site 1 and site
3 of the Gold Atlas dataset. The average over all patients is shown in
the bottom row.
patient mean (sd) absolute range diﬀerence [mm]
STB2 O B R BR
GA1.1-8 1.4 (1.0) 4.4 (2.9) 4.0 (2.8) 3.0 (2.1) 2.8 (2.1)
GA3.1-4 1.3 (0.9) 4.3 (2.5) 4.1 (2.5) 2.4 (2.0) 2.4 (2.0)
average 1.4 (1.0) 4.3 (2.7) 4.0 (2.7) 2.8 (2.1) 2.7 (2.0)
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The diﬀerence between the two sites is small: a maximum deviation of 0.6 mm
is observed for sCTR between the two sites. For the deformably registered MR
images, a signiﬁcant improvement can be observed compared to the original MR
image: from sCTO to sCTR, the absolute range diﬀerence decreases by 1.5 mm.
However, the diﬀerence between sCTR and BD-CTSTB2 is still larger than 1 mm on
average, indicating the impact of the conversion algorithm.
(a) pCT - sCTO (b) pCT - sCTB (c) pCT - sCTR (d) pCT - sCTBR
Figure 5.17.: Two-dimensional plots of the pencil-beam-wise range diﬀerences be-
tween sCTs and the pCT for patient GA3.3.
Figure 5.17 shows the 2D range diﬀerence plots for the same patient-case as for the
BD-CT study in section 5.2.2. Comparing subﬁgures (a) and (b), or (c) and (d)
to analyse the impact of the bias ﬁeld correction (BFC), only small changes in the
range diﬀerence can be seen. Subﬁgures (a) and (b) show large positive shifts all over
the plot, which reduce signiﬁcantly in subﬁgures (c) and (d). The remaining range
diﬀerences for sCTR and sCTBR can be related to imperfect bone representation in
the sCTs.
5.3.2. Gamma Analysis
The comparison of the DDpCT with the DDSTB2 and the DDsCTs using the 3D gamma
analysis is summarized in ﬁgure 5.18 for the PTVs. The gamma analysis is based on
a voxel-to-voxel comparison between two DDs. For this reason, GPRs for delineated
structures can only be evaluated for the exact same structures in both images. For
the sCTO and sCTB, the structures diﬀer from the structures in the pCT. Thus,
only the structures from the pCT are considered during gamma analysis. The result
will then represent changes in SPR in the path of the beam to that volume. Cases
in which the PTV volumes moves out of the high dose region, for example due to
a increase in bladder volume, however, will not be detected. The PTV in that case
could be drastically underdosed, while the GPR could still be close to 100 %.
Although none of the sCTs reaches the same mean GPR as the BD-CTSTB2, the
mean GPR for DDR and DDBR are above 97 %. The minimum GPRs for these two
sCTs are 94.4 % and 93.4 %, respectively, for patient GA1.3.
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Figure 5.18.: Mean gamma pass rates (GPRs) using a 2mm/2% criterion for the
PTV of DDSTB2 and DDsCTs (dots) for the Gold Atlas dataset. The
ranges (minimum to maximum GPRs) are shown as errorbars.
Overall, the diﬀerences between the bias ﬁeld corrected MR image and the respective
uncorrected image are small, as previously also observed for the absolute range
diﬀerences. The diﬀerence between the mean GPRs is 0.5 % for DDO/DDB, and
0.2 % for DDR/DDBR. Also the range of the GPRs seems almost unaﬀected by the
BFC.
The mean GPR increases and the range of GPRs decreases, when registering the
MR to the pCT. The mean GPR improves by approximately 3 percent points.
5.3.3. Dose Volume Histogram Analysis
The DVM diﬀerences from the DDsCTs relative to the DDpCTs averaged over all
patients are shown in table 5.12 for the PTV, the urinary bladder, the rectum,
and the RPW. The standard deviation of the 12 patients is given in brackets. For
comparison, the results for DDSTB2 are included.
Similar to the BD-CT results, the D2 and D50 are hardly impacted by the sCTs.
For all images investigated, the (absolute) relative diﬀerences are below 0.5 %. For
DDSTB2, DDR and DDBR they are even below 0.1 %. For D98, however, larger devi-
ations can be observed up to approximately -40 % for individual patients.
The diﬀerences between DDO and DDB, and between DDR and DDBR, respectively,
are small. This hints towards a minor impact of the BFC on the result. This ﬁnding
is in agreement with previous ﬁndings for absolute range diﬀerences and GPRs.
The results for DDO and DDB clearly show larger deviations than DDR and DDBR.
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Table 5.12.: Mean relative DVM diﬀerence and standard deviation (sd) of the 12 patients of the Gold Atlas dataset for the DDSTB2
and the diﬀerent DDsCTs.
mean (sd) relative DVM diﬀerences [%]
DVM STB2 O B R BR
PTV
D2 0.03 (0.07) -0.22 (0.13) -0.22 (0.10) 0.01 (0.10) 0.01 (0.11)
D50 0.02 (0.13) -0.48 (0.29) -0.50 (0.29) 0.08 (0.14) 0.05 (0.15)
D98 -1.55 (2.23) -24.54 (13.22) -24.64 (13.15) -2.87 (4.60) -3.55 (4.84)
urinary bladder
Dmax 0.39 (0.73) -2.60 (13.65) -2.54 (13.53) 0.92 (0.87) 0.96 (0.99)
D15 -1.28 (1.50) -34.73 (48.69) -34.85 (48.56) -0.92 (2.41) -1.33 (2.08)
rectum
Dmax 0.19 (0.64) -9.55 (13.29) -9.63 (13.26) 0.60 (0.58) 0.61 (0.58)
D15 -0.39 (0.69) -24.42 (42.68) -24.65 (42.77) -0.95 (0.94) -1.12 (0.84)
RPW
Dmax -0.02 (0.96) -21.23 (34.31) -21.12 (34.19) 0.75 (2.11) 0.63 (2.00)
D15 -0.70 (0.93) -25.10 (37.53) -25.10 (37.52) -1.61 (1.69) -1.59 (1.70)
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Also the standard deviations are much larger. For some DVMs, the standard devi-
ation already indicates that, although the majority of patients experiences a dose
reduction, few cases also experience a dose increase relative to the nominal DD.
Figures 5.19 and 5.20 show an exemplary case for the DVMs of the PTV and the
urinary bladder for patient GA1.3. This patient was chosen, as it was the only
patient that showed a critical exceeding of the acceptance band for DDR and DDBR.
It should be recalled that this patient also showed the lowest GPR for the PTV
among all patients. Deviations as in ﬁgure 5.19 up to approximately -40 % for D98
occur for four patients. For 10 out of 12 patients, DDO and DDB fail the acceptance
band criterion. The large range of rD uncertainty sampling for D98 for the sCTR
and sCTBR, comparable to the respective range for BD-CTSTB2, indicates a high
risk of exceeding the acceptance band under just a slight uncertainty of rD.
Figure 5.19.: DVMs for the pCT, BD-CTSTB2 and the sCTs for the PTV of patient
GA1.3 for one fraction.
Also for the bladder signiﬁcant DVM deviations of Dmax and D15 (an increase in
this case) can be observed for DDO and DDB. Thus, the showcased DVMs do not
behave like the DVM parameter in table 5.12 averaged over the patient cohort. In
this particular patient case, the bladder volume remained almost the same, however
internal anatomical changes shift the target volume out of the high dose region,
and the urinary bladder into the high dose region. For most patients in the Gold
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Figure 5.20.: DVMs for the pCT, BD-CTSTB2 and the sCTs for the urinary bladder
of patient GA1.3 for one fraction.
Atlas dataset, the bladder volume increases, which also shifts the PTV out of the
high dose region leading to a decrease in D98 and the urinary bladder into the high
dose region. This would result in an increase of Dmax for the urinary bladder and
a decrease in D98 for the PTV. This can be observed for seven patients, for which
the Dmax values also exceed the acceptance bands. The mean relative diﬀerence for
Dmax reported in table 5.12, however, is around -2.5 %. This negative mean can be
explained by the very strong decrease in Dmax of around -30 % for patient GA1.4,
which skews the mean to the negative.
The observable deviations of the DVMs for the DDR and DDBR are comparable to
the BD-CTs. The relative diﬀerences of D2 and D50 are very small and not clinically
relevant. For theD98, larger deviations occur (as already shown in table 5.12), which
are covered by the acceptance band for all patients except the showcased patient
GA1.3. The errorbar for the rD uncertainty sampling is overall covered by the
acceptance band, because the width of the acceptance band is dominated by the
set-up uncertainty sampling.
The clinical constraint Dmax < 100 % of prescribed dose , i.e. < 2.7 Gy(RBE) per
fraction for the urinary bladder is exceeded by 10 patients , and by ﬁve patients
for the rectum. Nonetheless, for no patient DDR or DDBR the DVMs exceed the
acceptance bands. For DDO and DDB, seven, two, and one patient exceeded the
acceptance bands for Dmax for the urinary bladder, the rectum, and the RPW,
respectively.
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5.3.4. Discussion
The presented sCT image generation is fast and robust because of the applied,
simple algorithm. The analysis of the sCT images included the original MR and
the corrected MR images. Two corrections were applied: a BFC to account for an
MR-intrinsic artefact, and deformable image registration to account for anatomical
changes in the patient between the CT and MR image acquisition. The latter is not
a correction in the sense that the anatomical change is a false reﬂection of the true
anatomy. However it impacts the comparison to the pCT as the ground truth. This
correction yields a comparison between the pCT and the sCT which is only aﬀected
by the BD values and the conversion algorithm.
Anatomical differences between MR and CT Due to the few BD classes used
for the sCT generation, only anatomical changes with respect to these classes can
be detected in the comparison between DDO and DDR. Most prominently, body
contour changes or shifts of bony structures are detected this way. Also interfraction
changes such as weight loss, i.e. a reduction of fat, can be detected. Organ motion
or changes such as a change in urinary bladder ﬁlling are hardly detectable without
the respective BD class. This is conﬁrmed by the large deviations observed for
DDO and DDB for the DVMs, covering anatomical changes of individual structures.
Similar observations can not be made in the range analysis and the gamma analysis,
as those only considered pCT-related volumes. Situation, where for example the
PTV for the GPR analysis shifts away from the high dose region, are not covered.
In this case, the dose at the original PTV position is just inﬂuenced by the changes
in SPR.
As the CT image generally is not applicable for structure delineation, it is advisable
to use the underlying MR image at this point as well. Its better soft tissue contrast
makes it more suitable for manual or even automated structure delineation. These
delineations can then easily be propagated to the sCT image. Reasons for updated
structures can be concerns with respect to the before-mentioned OARs, for example
the urinary bladder or the rectum, moving into high dose regions.
The original MR showed anatomical deformations in comparison to the pCT im-
age which could already be identiﬁed by visual inspections. The best parameter to
quantify these deformations is the change of urinary bladder volume, as the bladder
was segmented by clinicians on both the MR and the pCT. Among the 12 patients
analysed, the highest MR to pCT bladder ratio was 2.1 for patient GA1.5, while
the mean ratio for the dataset was 1.4. The results of the HIT dataset showed that
an additional error in the DD occurs, when the beam passes through the urinary
bladder, which was overwritten with a BD value for non-fatty soft tissue. This error
also might occur for the sCTO images for the Gold Atlas dataset, if the bladder
volume increases such that it move towards the target volume. However, a reference
pCT image with corresponding anatomy is missing. Thus, this error can not be
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distinguished from the pure anatomical changes and adds to the uncertainty of the
results. In future investigations, however, it is recommended to include the bladder
as an individual BD class. For this purpose, adequate segmentation techniques for
the MR image have to be developed.
To quantify the impact of the change in anatomy, sCTR, which was deformably reg-
istered to the pCT was added to the analysis. The deformable registration process
adds a source of uncertainty. The determination of the quality of the registration
is diﬃcult, especially if images of diﬀerent modalities like CT and MR are com-
pared. The large range of average magnitudes of residual displacements of ﬁducial
markers after deformable registration (2.3 mm - 7.4 mm) for MR/CT image pairs
of the prostate region presented by Brock (2010) indicate the diﬃculty of proper
registration. The most intuitive method for determination of registration quality is
the use of anatomical landmarks (Oh and Kim, 2017). Anatomical landmarks may
include points deﬁned by the observer in both images, whole organ delineations
or implanted seeds. Since the pre-contoured bladder volume was already used for
contour guidance during registration, it could not be utilized for analysis of regis-
tration quality. Nyholm et al. (2018) state that the registration parameter ﬁle in
the Gold Atlas dataset was optimized based on visual inspection of the registered
image. Thus, the uncertainty introduced by the registration can not be quantiﬁed
for this speciﬁc study and the results using deformably registered MR images have
to be handled with care.
For the mean absolute range diﬀerence and the GPR for the PTV, a clear improve-
ment of results could be observed when applying the deformable image registration.
The range diﬀerence decreased about 1.4 mm going from sCTO to sCTR. Also the
standard deviation decreased, which indicates more reliable results. The GPR in-
creased approximately by 3 percent points and the minimum GPR observed among
the 12 patients increased from less than 80 % to more than 90 %. The shift un-
certainty sampling of the pCT mostly covers the deviations of DVMs by sCTR and
sCTBR, making the results acceptable with regard to the acceptance band. The
relative DVM diﬀerences of sCTO and sCTB to the pCT show the drastic impact of
anatomical changes as, for example, the increase in urinary bladder ﬁlling. Speciﬁ-
cally, this change can shift the position of the prostate and thus the PTV by a few
millimetres. As a result, the PTV is not in the high dose region any more and not
covered adequately by the prescribed dose. This might indicate improper choice of
the safety margin, i.e., the additional volume of the PTV compared to the CTV. At
the same time, the urinary bladder moves into the high dose region, receiving higher
total dose. It is however questionable whether such strong anatomical changes would
actually be observed in the clinic, as most clinics have strict procedures regarding
pre-treatment defaecation and urination. It would have been helpful to assess the
observed diﬀerences, if the elapsed time between the CT and the MR acquisition
had been reported, and if respective protocols have been followed also for the MR.
Nonetheless, the observed deviations emphasize the need for pre-treatment imaging
and measures to correct for them if necessary.
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Bias field correction The second correction applied to the MR images, namely
the BFC, showed minor impact of the quality on the sCT images. In other words,
the number of BD classes is quite small. Thus, the identiﬁcation of the classes
is hardly aﬀected by intra-class intensity variations. The small improvements ob-
served for sCTB and sCTBR might be due to minor corrections, leading to a change
of tissue class. However, the overall impact is still very small. The low impact of
the BFC might be caused by the typical location of intensity deviations close to
the radio-frequency (RF) coils at the anterior and posterior sides of the body (cf.
section 2.1.2), while the beams typically enter the body laterally.
One clear advantage of the BFC, however, is its impact on the histogram of MR
images. The example of a histogram shown in ﬁgure 4.7 is derived from a corrected
MR image. For an uncorrected image, the two peaks are more smeared out, espe-
cially the one at higher intensity values. The valley position between the two peaks
is then harder to distinguish. With respect to automated techniques, the valley
position can easily be derived from the shown example. For this reason, BFC is
generally advisable.
For sCT images with more BD classes or covering the full HU range, the impact of
the bias ﬁeld and its correction is worth investigating as well, as more grey value-
based mis-classiﬁcation can be expected.
Impact of the different uncertainties The diﬀerentiation of the uncertainties
aﬀecting the DD on a sCT image is a complex problem. Several aspects have to
be considered: the use of BD values, the deformable image registration of the MR
to the CT image (and the propagation of contours which are also applied for the
pCT image), the approach for detecting the tissue classes in the MR image, and the
anatomical changes within the body from the acquisition of the CT to the acquisition
of the MR image.
While the use of BD values can be quantiﬁed accurately with the BD-CTs, the
remaining uncertainties are harder to diﬀerentiate and quantify. The sCTR and
sCTBR are aﬀected by the use of BD values, the deformable image registration,
and the detection of tissue classes in the MR. For example, a suboptimal choice
of the separation threshold for the non-fatty soft tissue peak (lower intensity) and
the fat peak (higher intensity) in the MR image can have systematic impact on the
DD. A higher threshold leads to a misclassiﬁcation of fat being overwritten with a
BD for soft tissue. This increases the water-equivalent path length (WEPL) of the
beam, leading to a shorter range. The same shorter range might occur, if due to
the registration relatively more fat or less non-fatty soft tissue is in the beam path.
Both are not distinguishable.
For the sCTO and sCTB, no registration error aﬀects the results, however the change
in anatomy can change the composition of tissue in the beam path, leading to
diﬀerent segmented tissue classes and diﬀerent BD values in the beam path. The
algorithm used for tissue class segmentation has the same impact (and uncertainties)
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as for sCTR and sCTBR.
For all three investigated analysis metrics, namely the range diﬀerence analysis,
the gamma analysis, and the analysis of relative DVM diﬀerences, the anatomical
diﬀerences lead to a degradation in metric results as compared to the sCT from the
rigidly registered MR image. The mean absolute range diﬀerence increases from
approximately 2.7 mm to 4.0 mm, the GPR for the PTV drops from 97 % to 94 %,
and all relative DVM diﬀerence increase in absolute terms going from sCTR to sCTO.
This degradation of the DD could be avoided by the use of MR-image guidance of
the treatment. To diﬀerentiate the impact quantitatively, either CT and MR have
to be acquired directly after each other for minimal anatomical changes, or, less
preferably, the registration error has to be quantiﬁed using applicable techniques.
The simulated range uncertainties showed that the sCT images would suﬀer from
similar changes in DD as the pCT. The set-up uncertainty in particular should
decrease signiﬁcantly just by the application of the MR imaging and was therefore
not sampled for the sCT images. As the range uncertainty had only minor impact
on OARs, the risk of unintentional overdose due to uncertainties could clearly be
reduced using the MR.
Bone segmentation and BD values From the visual inspection of the sCT image
example shown in ﬁgure 4.9 and the comparison to the pCT and BD-CT images,
it becomes clear that the identiﬁcation of bone and its subclasses has potential
for improvement. While the soft tissue classes show only minor diﬀerences in the
images, large areas of the pubic bone (the central top bone) are not detected in the
MR image. The threshold of 0.5 in the probability mask of bone applied in this
study might introduce an uncertainty to the bone segment. In future studies, other
(lower) thresholds should be tested and compared to the present study. Also the
diﬀerentiation of soft bone and hard bone generates a rather spotty pattern, instead
of solid hard bone areas. As mentioned before, previous studies indicated that more
sub-classes within bone are necessary for accurate dose distributions (Vanderstraeten
et al., 2007). The observed good performance with only two sub-classes in this
study might originate from the applied dose-calculation engine. Studies comparing
a pencil-beam algorithm with Monte Carlo techniques showed discrepancies in the
DD particularly behind bones and at bone-tissue interfaces (Paganetti et al., 2008).
Monte Carlo techniques could help to investigate the accuraty of the DDs in the
bone and its sub-classes in sCT images in the future.
The probability mask for bone is certainly a useful tool. However, more patients
should be included in its generation to make it more robust. It should also be noted
that a gender-speciﬁc probability mask has to be generated, as the female pelvis
and the pelvic bone have diﬀerent anatomy than the male counterpart.
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Potential improvement of BD values In the discussion in section 5.2.3 it was
already mentioned that the usage of DECT images as pCT images would reduce the
error of the HLUT. Generally, the comparison of both the BD-CTs and sCTs to the
pCT might yield good results. However the diﬀerence to the actually delivered DD
can not be estimated. Future investigations could possibly reduce this uncertainty.
With the use of DECT images, or measurements of the SPR of the required tissue
classes, e.g. fat, muscle, cortical bone, etc. For the latter, SPR could be measured
directly via shoot-through measurements of monoenergetic proton beams. The mea-
sured values could then directly be applied as BD overwrites. Mo¨hler et al. (2018)
performed such experiments using pork tissue samples. Measurements of human
tissue are still pending, and for various reasons can not be expected in the near
future.
Impact of the MR sequence In the presented study, so far only a T1-weighted MR
image was investigated. The advantage of this image is that such MR sequences are
clinical standard and provide suﬃcient contrast between cortical bone, fat, and non-
fatty soft tissue. Physicians are trained in interpreting these images and using them,
for example, for organ delineations. Dedicated sequences such as ulta short echo time
(UTE) sequences may improve bone segmentation. It should be investigated further,
if the conversion of bone from MR to sCT improves when using a single UTE-MR-
image as input for the sCT generation, without sacriﬁcing the accuracy of the soft
tissue classiﬁcation. On the other hand, the absence of bone signal is also useful
information to distinguish bone from other tissues. As bone is quite predictable in
terms of location as compared to internal gas for example, this information can be
used to make the separation between air and bone, as it was done in the presented
study. The modular framework of this thesis would enable fast adaptation of the
analysis workﬂow for comparison with the results presented in this study.
Comparison to literature Although several studies have been reported in the lit-
erature for sCT images for proton therapy, only two studies focused on prostate
cancer (Koivula et al., 2016; Maspero et al., 2017). As the requirements for the im-
age and the required granularity are diﬀerent, for example, in the head region, direct
comparison is only reasonable for the prostate studies. Koivula et al. (2016) applied
the so-called dual model conversion technique. The dual model assigns a piece-wise
linear conversion function for soft tissues, and a second-order polynomial conversion
function for bone. They reported a mean GPR (2mm/2%) for the volume receiving
more than 10 % of prescribed dose of 98.6 %. The minimum GPR of the 10 patients
that were investigated was 97.2 %. Maspero et al. (2017) adapted a commercial
BD overwrite technique with BD values for internal and outside air, soft tissue, fat,
soft and hard bone. The BD values were derived from the literature. Compared
to the commercial solution, they introduced the internal air class and adapted the
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BD values for bones such that the range diﬀerence between the pCT and the sCT
was minimized for two patient cases. They reported a mean GPR of 98.4 % and a
minimum of 96.4 % with the same criteria as Koivula et al. (2016). In both studies,
the mean GPR is about 1 percent point higher than in this study, also the minimum
GPR is higher. It should however be noted, that the volume receiving more than
10 % of prescribed dose is much larger than the PTV volume investigated in this
study. As the volume of GPR failure is fairly condensed for proton therapy around
the target volume, an increase in GPR can be expected for a larger volume.
Maspero et al. (2017) also reported range analysis of the proton beams. However, in-
cluding only average values of the median range diﬀerences of the individual patients.
They reported a value of 0.1 mm, while no absolute range diﬀerences or minimum
and maximum range diﬀerences for individual pencil-beams were reported. For this
reason, a comparison to the presented values is not possible. The decrease in D98
which was observed here was less pronounced for both studies in comparison (< 1 %
estimated from the boxplots). Since Maspero et al. (2017) had very similar BD
classes as in this study, the reasons for the stronger decrease observed here might
most probably by either the bone segmentation technique or the choice of overwrite
values. As further investigations have been recommended before in this study, bone
is a promising candidate for improvement.
Comments on the framework The BFC correction were performed using the
external software Slicer, the deformable image registration was performed using
elastix. Although the deformable image registration is not required in a clinical work
ﬂow any more, both the BFC and the registration should be implemented in matlab
for the integration into the matRad-based framework in the future. Combinations
with existing tools, for example for deformable image registration in matlab, are
conceivable.
6. Summary and Outlook
Magnetic resonance (MR)-guided proton therapy could reduce the uncertainties from
set-up and inter- and intra-fractional anatomical changes, without an additional
dose burden to the patient. MR images, however, lack stopping power ratio (SPR)
information of the human tissue, which is necessary for dose calculation. To enable
dose calculation, a possible solution is the generation of so-called synthetic computed
tomography (sCT) images from the MR image.
The generalization and compatibility of sCT generation techniques is currently hin-
dered by the fact that MR images from diﬀerent clinics are not comparable. The
reasons are varying MR scanners and/or MR sequences used at diﬀerent clinics.
From a practical point of view, MR images should ideally be acquired and processes
when the patient is already in treatment position. Thus, the aim for this investi-
gation was to generate sCT images for proton therapy of prostate cancer in a fast,
robust and compatible fashion.
The required granularity of the tissue classiﬁcation of the planning computed to-
mography (pCT) image was investigated in the ﬁrst part of this study as a measure
of robustness: the lass tissue classes have to be identiﬁed in an MR image in the ﬁnal
step of this thesis, the lower is the probability of misclassiﬁcation and the higher
is the robustness of the approach. In the second part, a recommended set of tissue
classes, i.e. the result of the granularity investigation in the ﬁrst part, was identiﬁed
in an MR image. The MR image was deformably registered to the pCT to over-
come anatomical diﬀerences between the two images. A simple and fast conversion
of MR to sCT image was applied: bones were separated from air via a grey value
threshold in the MR histogram and a bone probability mask. The remaining tissue
was segmented using only histogram-based thresholds. In the last part, the original
MR image was converted to a sCT image using the same technique as in the second
part.
For photon therapy, the granularity study showed that four tissue classes, namely
air, fat, non-fatty soft tissue and bone, overwritten with bulk density (BD) values
are dosimetrically indistinguishable from the pCT. Using photon therapy in the ﬁrst
place was used for framework development and as an independent veriﬁcation of the
methods and results, as much literature is available for comparison. For proton
therapy, however, ﬁve tissue classes are required to yield good dosimetric agreement
with the pCT, namely, air, fat, non-fatty soft tissue, soft bone and hard bone.
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While grey-value based tissue classiﬁcation for BD overwrite within the pCT is
straightforward, the ﬁve tissue classes from the granularity study also had to be
identiﬁed in the MR image. Especially in standard MR images, like the applied
T1-weighted sequence, tissues with similar signal intensity like air and bone pose a
challenge to distinguish. A solution based on a probability mask of bony tissue in
the male pelvis accelerated and simpliﬁed the bone/air segmentation in the image.
A fast and robust method for soft tissue identiﬁcation was the application of a
histogram-based threshold. The implementation of this approach was facilitated by
the bias ﬁeld correction (BFC), as the two main tissue classes fat and non-fatty
soft tissue became better separable in the histogram. As the threshold is derived
from the histogram dynamically, any sequence from any scanner can theoretically
be used, as long as adequate water/fat separation is possible.
The developed modular framework is an excellent tool to test individual aspects of
sCT generation. Upon demand, single modules can be exchanged and the overall
results can be compared to previous results. This is particularly helpful, if, for
example, two MR sequences or two methods to extract bone from the MR should
be compared. Further applications are conceivable.
In this study, the comparison of the original, rigidly registered and the deformably
registered MR images showed minor dose deviations of the sCT compared to the
dosimetric impact of anatomical diﬀerences. The uncertainty sampling of the set-up
and range uncertainties was introduced as a new method to evaluate and contextu-
alize the observed dosimetric diﬀerences of the sCT images to the pCT. The large
range of set-up uncertainties observed for some cases can be reduced by the applica-
tion of MR-guidance for set-up and position veriﬁcation, even during treatment.
Further improvement can be expected in future work when including a tissue class
for the urinary bladder, and a ﬁner subsampling for bone. A reﬁnement of the
bone segmentation in particular should be investigated in the future using dedicated
sequences with a grey value representation for bony tissue, without neglecting the
applicability of such sequences to segment soft tissues. Patient speciﬁc values for
BDs can be derived from any pelvis computed tomography (CT) image available
for the patient. Alternatively, the application of cohort values can be investigated
in future studies. The BD values can also be derived prior to the MR image, not
prolonging the procedure of sCT generation just before or during treatment.
In conclusion, sCT images could be successfully generated based on a clinically stan-
dard MR sequence and veriﬁed dosimetrically against the pCT. Few tissue classes,
which have to be identiﬁed and replaced with BD values, could be derived robustly
and fast from an MR image. MR-guidance for proton therapy is thus an appli-
cable tool for treatment improvement. The technology for live imaging should be
advanced in the near future to tap the full potential of MR-guidance.
Appendices
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A. Deformable Image Registration
Parameter ﬁle for deformable image registrations using elastix (cf. section 4.3) used
in this thesis to register MR images to CT images. The parameter ﬁle can be found
in the data repository for the Gold Atlas dataset (more details can be found in the
publication by Nyholm et al. (2018)).
(FixedInternalImagePixelType "float")
(MovingInternalImagePixelType "float")
(FixedImageDimension 3)
(MovingImageDimension 3)
(UseDirectionCosines "true")
// **************** Main Components **************************
(Registration "MultiMetricMultiResolutionRegistration")
(ResampleInterpolator "FinalBSplineInterpolator")
(Resampler "OpenCLResampler")
(OpenCLResamplerUseOpenCL "true")
(FixedImagePyramid "FixedSmoothingImagePyramid"
"FixedSmoothingImagePyramid" )
(MovingImagePyramid "MovingSmoothingImagePyramid"
"MovingSmoothingImagePyramid" )
(Interpolator "BSplineInterpolator" "BSplineInterpolator" )
(Metric "NormalizedMutualInformation" "AdvancedMeanSquares")
(Metric0Weight 30000)
(Metric1Weight 1)
(Optimizer "AdaptiveStochasticGradientDescent")
(Transform "BSplineTransform")
// ******************** Multiresolution **********************
(NumberOfResolutions 3)
(ImagePyramidSchedule 4.0 4.0 4.0 2.0 2.0 2.0 1.0 1.0 1.0)
// ***************** Transformation **************************
(FinalGridSpacingInPhysicalUnits 60 60 60)
(GridSpacingSchedule 4 2 1)
(AutomaticScalesEstimation "true")
97
98 Appendix A Deformable Image Registration
(AutomaticTransformInitialization "false")
(HowToCombineTransforms "Compose")
// ******************* Optimizer ****************************
(MaximumNumberOfIterations 500 500 500)
// ******************* Similarity measure *********************
(NumberOfHistogramBins 64 96 96)
(ErodeMask "false")
// **************** Image sampling **********************
(NumberOfSpatialSamples 3000)
(NewSamplesEveryIteration "true")
(ImageSampler "RandomCoordinate" "RandomCoordinate")
(CheckNumberOfSamples "true")
(RequiredRatioOfValidSamples 0.01)
(UseRandomSampleRegion "true")
(SampleRegionSize 150 150 70)
(MaximumNumberOfSamplingAttempts 100)
// ************* Interpolation and Resampling ****************
(BSplineInterpolationOrder 2)
(FinalBSplineInterpolationOrder 3)
(DefaultPixelValue -1)
(WriteResultImage "false")
(ResultImagePixelType "short")
(ResultImageFormat "mhd")
The MR image was used as moving image, the CT image as ﬁxed. The bladder con-
tour in binary format (0/255) was used as second input image each, the binary body
contour (0/255) derived from the CT images was used as mask. The registration
command was
elastix -f0 <CT> -f1 <CT bladder> -fMask <CT contour> -m0 <MR>
-m1 <MR bladder> -out <result output directory> -p <parameter file>
The resulting transform ﬁle was then applied to the MR image and all binary seg-
mentations of the MR
transformix -in <MR/segmentation> -out <transformed output directory>
-tp <result output directory\transform>
For the segmentation transformations, the FinalBSplineInterpolationOrder was
changed from 3 to 0 to avoid artefacts when deforming binary images.
B. List of Publications
Conferences
Thesis ﬁndings have been presented in the following contributions to conferences:
Handrack, J., Bangert, M., Mo¨hler. C., Bostel, T., Greilich, S. (2018). Simpli-
ﬁcation of relative electron density information in synthetic CT images for dose
calculation. ESTRO 37, Barcelona, Spain. (Poster)
Handrack, J., Bangert, M., Mo¨hler. C., Bostel, T., Greilich, S. (2018). Simpliﬁed
CT images for dose calculation for pelvic tumour patients. MR in RT, Utrecht, The
Netherlands. (Poster)
Handrack, J., Bangert, M., Mo¨hler. C., Ellerbrock, M., Greilich, S. (2018). Syn-
thetic CT accuracy for proton therapy of pelvic cancer. DGMP Tagung, Nu¨rnberg,
Germany. (Poster)
Handrack, J., Bangert, M., Mo¨hler. C., Ellerbrock, M., Greilich, S. (2019). Assess-
ment of bulk-density CT accuracy for MR-guided proton therapy of prostate cancer.
ESTRO 38, Milano, Italy. (Poster)
Manuscripts
In the following manuscript, ﬁndings of section 5.1 are presented:
Handrack, J., Bangert, M., Mo¨hler. C., Bostel, T., Greilich, S. (2019). Towards a
generalized development of synthetic CT images and assessment of their dosimetric
accuracy. (in revision at Acta Oncologica)
99

Bibliography
Andreasen, D., Leemput, K. V., Hansen, R. H., Andersen, J. A. L., & Edmund, J. M.
(2015). Patch-based generation of a pseudo CT from conventional MRI sequences
for MRI-only radiotherapy of the brain. Medical Physics, 42(4):1596–1605. 20
Austin-Seymour, M., Chen, G. T., Rosenman, J., Michalski, J., Lindsley, K., &
Goitein, M. (1995). Tumor and target delineation: Current research and fu-
ture challenges. International Journal of Radiation Oncology Biology Physics,
33(5):1041–1052. 19
Beavis, A. W., Gibbs, P., Dealey, R. A., & Whitton, V. J. (1998). Radiotherapy
treatment planning of brain tumours using MRI alone. The British Journal of
Radiology, 71(845):544–548. PMID: 9691900. 19
Berger, M., Hubbell, J., Seltzer, S., Chang, J., Coursey, J., Sukumar, R., Zucker,
D., & Olsen, K. XCOM: Photon Cross Sections Database. Available at:
https://www.nist.gov/pml/xcom-photon-cross-sections-database [Jul 2019]. 9
Bethe, H. (1930). Zur Theorie des Durchgangs schneller Korpuskularstrahlen durch
Materie. Annalen der Physik, 397(3):325–400. 15
Bloch, F. (1946). Nuclear induction. Physical Review, 70:460–474. 4
Borras, J. M., Barton, M., Grau, C., Corral, J., Verhoeven, R., Lemmens, V., van
Eycken, L., Henau, K., Primic-Zakelj, M., Strojan, P., Trojanowski, M., Dyzmann-
Sroka, A., Kubiak, A., Gasparotto, C., Defourny, N., Malicki, J., Dunscombe, P.,
Coﬀey, M., & Lievens, Y. (2015). The impact of cancer incidence and stage on
optimal utilization of radiotherapy: Methodology of a population based analysis
by the ESTRO-HERO project. Radiotherapy and Oncology, 116(1):45–50. 1
Bortfeld, T., Schlegel, W., & Rhein, B. (1993). Decomposition of pencil beam
kernels for fast dose calculations in three-dimensional treatment planning. Medical
Physics, 20(2):311–318. 12
Bostel, T., Nicolay, N. H., Grossmann, J. G., Mohr, A., Delorme, S., Echner, G.,
Ha¨ring, P., Debus, J., & Sterzing, F. (2014). MR-guidance – a clinical study to
evaluate a shuttle- based MR-linac connection to provide MR-guided radiother-
apy. Radiation Oncology, 9(1). 25
101
102 Bibliography
Bostel, T., Pfaﬀenberger, A., Delorme, S., Dreher, C., Echner, G., Haering, P.,
Lang, C., Splinter, M., Laun, F., Mu¨ller, M., Ja¨kel, O., Debus, J., Huber, P. E.,
Sterzing, F., & Nicolay, N. H. (2018). Prospective feasibility analysis of a novel
oﬀ-line approach for MR-guided radiotherapy. Strahlentherapie und Onkologie,
194(5):425–434. 25
Brock, K. K. (2010). Results of a Multi-Institution Deformable Registration Ac-
curacy Study (MIDRAS). International Journal of Radiation Oncology Biology
Physics, 76(2):583 – 596. 88
Bushberg, J. T., Seibert, J. A., Jr., E. M. L., & Boone, J. M. (2012). The essential
physics of medical imaging, (3. ed.). Wolters Kluwer, Lippincott Williams and
Wilkins. 10
Chen, L., Price, R. A., Wang, L., Li, J., Qin, L., McNeeley, S., Ma, C. M. C.,
Freedman, G. M., & Pollack, A. (2004). MRI-based treatment planning for ra-
diotherapy: Dosimetric veriﬁcation for prostate IMRT. International Journal of
Radiation Oncology Biology Physics, 60(2):636–647. 19, 20
Chen, S., Qin, A., Zhou, D., & Yan, D. (2018). Technical Note: U-net-generated
synthetic CT images for magnetic resonance imaging-only prostate intensity-
modulated radiation therapy treatment planning. Medical Physics, 45(12):5659–
5665. 21
Demol, B., Boydev, C., Korhonen, J., & Reynaert, N. (2016). Dosimetric character-
ization of MRI-only treatment planning for brain tumors in atlas-based pseudo-
CT images generated from standard T1-weighted MR images. Medical Physics,
43(12):6557–6568. 20
Diwakar, M. & Kumar, M. (2018). A review on CT image noise and its denoising.
Biomedical Signal Processing and Control, 42:73–88. 34
Doemer, A., Chetty, I. J., Glide-Hurst, C., Nurushev, T., Hearshen, D., Pantelic,
M., Traughber, M., Kim, J., Levin, K., Elshaikh, M. A., Walker, E., & Movsas, B.
(2015). Evaluating organ delineation, dose calculation and daily localization in an
open-MRI simulation workﬂow for prostate cancer patients. Radiation Oncology,
10(1):37–37. 37
Edmund, J. M., Kjer, H. M., Leemput, K. V., Hansen, R. H., Andersen, J. A. L.,
& Andreasen, D. (2014). A voxel-based investigation for MRI-only radiother-
apy of the brain using ultra short echo times. Physics in Medicine and Biology,
59(23):7501–7519. 2, 22
Edmund, J. M. & Nyholm, T. (2017). A review of substitute CT generation for
MRI-only radiation therapy. Radiation Oncology, 12(1). 2, 33
Bibliography 103
Eilertsen, K., Vestad, L. N. T. A., Geier, O., & Skretting, A. (2008). A simulation
of MRI based dose calculations on the basis of radiotherapy planning CT images.
Acta Oncologica, 47(7):1294–1302. 20, 57
Fiorino, C., Reni, M., Bolognesi, A., Bonini, A., Cattaneo, G. M., & Calandrino, R.
(1998a). Set-up error in supine-positioned patients immobilized with two diﬀerent
modalities during conformal radiotherapy of prostate cancer. Radiotherapy and
Oncology, 49(2):133 – 141. 18
Fiorino, C., Reni, M., Bolognesi, A., Cattaneo, G. M., & Calandrino, R. (1998b).
Intra- and inter-observer variability in contouring prostate and seminal vesi-
cles: implications for conformal treatment planning. Radiotherapy and Oncology,
47(3):285–292. 17
Han, X. (2017). Mr-based synthetic ct generation using a deep convolutional neural
network method. Medical Physics, 44(4). 21
Hong, L., Goitein, M., Bucciolini, M., Comiskey, R., Gottschalk, B., Rosenthal,
S., Serago, C., & Urie, M. (1996). A pencil beam algorithm for proton dose
calculations. Physics in Medicine and Biology, 41(8):1305–1330. 16
Hsu, S.-H., Cao, Y., Huang, K., Feng, M., & Balter, J. M. (2013). Investigation of
a method for generating synthetic CT models from MRI scans of the head and
neck for radiation therapy. Physics in Medicine and Biology, 58(23):8419–8435.
21
ICRU (2010). Prescribing, recording,and reporting photon-beam IMRT, Report 83.
Journal of the International Commission on Radiation Units and Measurements,
10(1). 19
Johansson, A., Karlsson, M., & Nyholm, T. (2011). Ct substitute derived from mri
sequences with ultrashort echo time. Medical Physics, 38(5):2708–2714. 21
Johnstone, E., Wyatt, J. J., Henry, A. M., Short, S. C., Sebag-Monteﬁore, D., Kelly,
C. G., McCallum, H. M., & Speight, R. (2017). A systematic review of synthetic
CT generation methodologies for use in MRI-only radiotherapy. International
Journal of Radiation Oncology Biology Physics, 100(1):199–217. 2
Jonsson, J. H., Karlsson, M. G., Karlsson, M., & Nyholm, T. (2010). Treatment
planning using MRI data: an analysis of the dose calculation accuracy for diﬀerent
treatment regions. Radiation Oncology, 5(1):62–62. 20, 37
Kapanen, M. & Tenhunen, M. (2012). T1/T2*-weighted MRI provides clinically
relevant pseudo-CT density data for the pelvic bones in MRI-only based radio-
therapy treatment planning. Acta Oncologica, 52(3):612–618. 21
104 Bibliography
Khoo, V., Dearnaley, D., Finnigan, D., Padhani, A., Tanner, S., & Leach, M. (1997).
Magnetic resonance imaing (MRI): considerations and applications in radiother-
apy treatment planning. Radiotherapy and Oncology, 42:1–15. 19
Klein, S., Staring, M., Murphy, K., Viergever, M. A., & Pluim, J. P. (2010). elastix:
a toolbox for intensity-based medical image registration. IEEE Transactions on
Medical Imaging, 29(1):196–205. 29, 32
Koivula, L., Wee, L., & Korhonen, J. (2016). Feasibility of MRI-only treatment
planning for proton therapy in brain and prostate cancers: Dose calculation ac-
curacy in substitute CT images. Medical Physics, 43(8):4634–4642. 2, 21, 22, 77,
91, 92
Korsholm, M. E., Waring, L. W., & Edmund, J. M. (2014). A criterion for the
reliable use of MRI-only radiotherapy. Radiation Oncology, 9(16). 20, 37
Kraus, K. M., Ja¨kel, O., Niebuhr, N. I., & Pfaﬀenberger, A. (2017). Generation of
synthetic ct data using patient speciﬁc daily mr image data and image registration.
Physics in Medicine and Biology, 62(4):1358–1377. 20
Lee, Y. K., Bollet, M., Charles-Edwards, G., Flower, M. A., Leach, M. O., McNair,
H., Moore, E., Rowbottom, C., & Webb, S. (2003). Radiotherapy treatment
planning of prostate cancer using magnetic resonance imaging alone. Radiotherapy
and Oncology, 66(2):203–216. 19, 20, 37
Lomax, A. J. (2008). Intensity modulated proton therapy and its sensitivity to
treatment uncertainties 2: the potential eﬀects of inter-fraction and inter-ﬁeld
motions. Physics in Medicine and Biology, 53(4):1043–1056. 1, 17
Low, D. A., Harms, W. B., Mutic, S., & Purdy, J. A. (1998). A technique for the
quantitative evaluation of dose distributions. Medical Physics, 25(5):656–661. 42
Marks, L. B., Yorke, E. D., Jackson, A., Haken, R. K. T., Constine, L. S., Eis-
bruch, A., Bentzen, S. M., Nam, J., & Deasy, J. O. (2010). Use of normal tissue
complication probability models in the clinic. International Journal of Radiation
Oncolog Biology Physics, 76(3):S10–S19. 11, 53
Maspero, M., Savenije, M. H. F., Dinkla, A. M., Seevinck, P. R., Intven, M. P. W.,
Jurgenliemk-Schulz, I. M., Kerkmeijer, L. G. W., & van den Berg, C. A. T. (2018).
Dose evaluation of fast synthetic-CT generation using a generative adversarial net-
work for general pelvis MR-only radiotherapy. Physics in Medicine and Biology,
63(18):185001. 21
Maspero, M., van den Berg, C. A. T., Landry, G., Belka, C., Parodi, K., Seevinck,
P. R., Raaymakers, B. W., & Kurz, C. (2017). Feasibility of MR-only proton
dose calculations for prostate cancer radiotherapy using a commercial pseudo-CT
generation method. Physics in Medicine and Biology, 62(24):9159–9176. 2, 22,
91, 92
Bibliography 105
Mu¨ller, L.-R. (2016). Commissioning of an Uncertainty Analysis Tool for IMPT.
Master’s thesis, Department of Physics and Astronomy, University of Heidelberg.
46
Mo¨hler, C., Russ, T., Wohlfahrt, P., Elter, A., Runz, A., Richter, C., & Greilich, S.
(2018). Experimental veriﬁcation of stopping-power prediction from single- and
dual-energy computed tomography in biological tissues. Physics in Medicine and
Biology, 63(2):025001. 91
Nyholm, T., Nyberg, M., Karlsson, M. G., & Karlsson, M. (2009). Systematisation of
spatial uncertainties for comparison between a MR and a CT-based radiotherapy
workﬂow for prostate treatments. Radiation Oncology, 4(1):54–54. 17, 19
Nyholm, T., Svensson, S., Andersson, S., Jonsson, J., Sohlin, M., Gustafsson, C.,
Kjelle´n, E., So¨derstro¨m, K., Albertsson, P., Blomqvist, L., Zackrisson, B., Ols-
son, L. E., & Gunnlaugsson, A. (2018). MR and CT data with multiobserver
delineations of organs in the pelvic area-Part of the Gold Atlas project. Medical
Physics, 45(3):1295–1300. 23, 26, 29, 30, 32, 78, 88, 97
Oh, S. & Kim, S. (2017). Deformable image registration in radiation therapy. Ra-
diation Oncology Journal, 35(2):101–111. 31, 88
Paganetti, H. (2012). Range uncertainties in proton therapy and the role of monte
carlo simulations. Physics in Medicine and Biology, 57(11):R99–R117. 77
Paganetti, H., Jiang, H., Parodi, K., Slopsema, R., & Engelsman, M. (2008). Clinical
implementation of full Monte Carlo dose calculation in proton beam therapy.
Physics in Medicine and Biology, 53(17):4825–4853. 90
Pileggi, G., Speier, C., Sharp, G. C., Garcia, D. I., Catana, C., Pursley, J., Amato,
F., Seco, J., & Spadea, M. F. (2018). Proton range shift analysis on brain pseudo-
CT generated from T1 and T2 MR. Acta Oncologica, 57(11):1521–1531. 2, 22
Rank, C. M., Hu¨nemohr, N., Nagel, A. M., Ro¨thke, M. C., Ja¨kel, O., & Greilich,
S. (2013). MRI-based simulation of treatment plans for ion radiotherapy in the
brain region. Radiotherapy and Oncology, 109(3):414–418. 2, 21, 22
Roberson, P. L., McLaughlin, P. W., Narayana, V., Troyer, S., Hixson, G. V., &
Kessler, M. L. (2005). Use and uncertainties of mutual information for computed
tomography/magnetic resonance (CT/MR) registration post permanent implant
of the prostate. Medical Physics, 32(2):473–482. 17
Roeske, J. C., Forman, J. D., Mesina, C. F., He, T., Pelizzari, C. A., Fontenla, E.,
Vijayakumar, S., & Chen, G. T. (1995). Evaluation of changes in the size and
location of the prostate, seminal vesicles, bladder, and rectum during a course
of external beam radiation therapy. International Journal of Radiation Oncology
Biology Physics, 33(5):1321–1329. 18
106 Bibliography
Schad, L. R., Blu¨ml, S., Hawighorst, H., Wenz, F., & Lorenz, W. J. (1994). Radio-
surgical treatment planning of brain metastases based on a fast, three-dimensional
MR imaging technique. Magnetic Resonance Imaging, 12(5):811–819. 20
Schaﬀner, B. & Pedroni, E. (1998). The precision of proton range calculations in
proton radiotherapy treatment planning: experimental veriﬁcation of the relation
between CT-HU and proton stopping power. Physics in Medicine and Biology,
43(6):1579–1592. 17
W. Schlegel, C. Karger, & O. Ja¨kel, ed. (2018). Medizinische Physik. Springer
Spektrum. 14
Schneider, U. & Pedroni, E. (1995). Proton radiography as a tool for quality control
in proton therapy. Medical Physics, 22(4):353–363. 76
Schulte, R., Bashkirov, V., Tianfang Li, Zhengrong Liang, Mueller, K., Heimann, J.,
Johnson, L. R., Keeney, B., Sadrozinski, H. F. ., Seiden, A., Williams, D. C., Lan
Zhang, Zhang Li, Peggs, S., Satogata, T., & Woody, C. (2004). Conceptual design
of a proton computed tomography system for applications in proton radiation
therapy. IEEE Transactions on Nuclear Science, 51(3):866–872. 76
Siversson, C., Nordstro¨m, F., Nilsson, T., Nyholm, T., Jonsson, J., Gunnlaugsson,
A., & Olsson, L. E. (2015). Technical Note: MRI only prostate radiotherapy plan-
ning using the statistical decomposition algorithm. Medical Physics, 42(10):6090–
6097. 2, 20
Spadea, M. F., Pileggi, G., Zaﬃno, P., Salome, P., Catana, C., Izquierdo-Garcia,
D., Amato, F., & Seco, J. (2019). Deep Convolution Neural Network (DCNN)
multi-plane approach to synthetic CT generation from MR images - application
in brain proton therapy. International Journal of Radiation Oncology Biology
Physics. 2, 21, 22
Tanner, S. F., Finnigan, D. J., Khoo, V. S., Mayles, P., Dearnaley, D. P., & Leach,
M. O. (2000). Radiotherapy planning of the pelvis using distortion corrected
MR images: the removal of system distortions. Physics in Medicine and Biology,
45(8):2117–2132. 19
Tustison, N. J., Avants, B. B., Cook, P. A., Zheng, Y., Egan, A., Yushkevich, P. A.,
& Gee, J. C. (2010). N4ITK: Improved N3 Bias Correction. IEEE Transactions
on Medical Imaging, 29(6):1310–1320. 32
Tyagi, N., Fontenla, S., Zhang, J., Cloutier, M., Kadbi, M., Mechalakos, J., Zelefsky,
M., Deasy, J., & Hunt, M. (2017). Dosimetric and workﬂow evaluation of ﬁrst
commercial synthetic CT software for clinical use in pelvis. Physics in Medicine
and Biology, 62(8):2961–2975. 2, 20, 57, 58
Bibliography 107
Uh, J., Merchant, T. E., Li, Y., Li, X., & Hua, C. (2014). MRI-based treatment
planning with pseudo CT generated through atlas registration. Medical Physics,
41(5). 20
van Herk, M. (2004). Errors and margins in radiotherapy. Seminars in Radiation
Oncology, 14(1):52–64. 46
Vanderstraeten, B., Chin, P. W., Fix, M., Leal, A., Mora, G., Reynaert, N., Seco,
J., Soukup, M., Spezi, E., Neve, W. D., & Thierens, H. (2007). Conversion of CT
numbers into tissue parameters for monte carlo dose calculations: a multi-centre
study. Physics in Medicine and Biology, 52(3):539–562. 79, 90
Weishaupt, D., Ko¨chli, V. D., Marincek, B., Froehlich, J. M., Nanz, D., & Prueß-
mann, K. P. (2014). Wie funktioniert MRI?, (7., u¨berarb. und erg. auﬂ. ed.).
Springer. Engl. Ausg.: How does MRI work? 6
White, D. R., Griﬃth, R. V., & Wilson, I. J. (2016). Report 46. Journal of the
International Commission on Radiation Units and Measurements, os24(1). 37, 56
Wieser, H.-P., Cisternas, E., Wahl, N., Ulrich, S., Stadler, A., Mescher, H., Mu¨ller,
L.-R., Klinge, T., Gabrys, H., Burigo, L., Mairani, A., Ecker, S., Ackermann, B.,
Ellerbrock, M., Parodi, K., Ja¨kel, O., & Bangert, M. (2017). Development of the
open-source dose calculation and optimization toolkit matRad. Medical Physics,
44(6):2556–2568. 29
Wiesinger, F., Bylund, M., Yang, J., Kaushik, S., Shanbhag, D., Ahn, S., Jons-
son, J. H., Lundman, J. A., Hope, T., Nyholm, T., Larson, P., & Cozzini, C.
(2018). Zero TE-based pseudo-CT image conversion in the head and its ap-
plication in PET/MR attenuation correction and MR-guided radiation therapy
planning. Magnetic Resonance in Medicine. 21
Wilson, R. R. (1946). Radiological use of fast protons. Radiology, 47(5). 1
Witte, M. G., van der Geer, J., Schneider, C., Lebesque, J. V., Alber, M., & van
Herk, M. (2007). IMRT optimization including random and systematic geometric
errors based on the expectation of TCP and NTCP. Medical Physics, 34(9):3544–
3555. 46
Wohlfahrt, P., Mo¨hler, C., Stu¨tzer, K., Greilich, S., & Richter, C. (2017). Dual-
energy CT based proton range prediction in head and pelvic tumor patients.
Radiotherapy and Oncology, 125(3):526–533. 76
Woodard, H. Q. & White, D. R. (1986). The composition of body tissues. The
British Journal of Radiology, 59(708):1209–1218. 17
Wu, J., Haycocks, T., Alasti, H., Ottewell, G., Middlemiss, N., Abdolell, M., Warde,
P., Toi, A., & Catton, C. (2001). Positioning errors and prostate motion during
108 Bibliography
conformal prostate radiotherapy using on-line isocentre set-up veriﬁcation and
implanted prostate markers. Radiotherapy and Oncology, 61(2):127 – 133. 18
Zheng, W., Kim, J. P., Kadbi, M., Movsas, B., Chetty, I. J., & Glide-Hurst, C. K.
(2015). Magnetic Resonance–Based Automatic Air Segmentation for Generation
of Synthetic Computed Tomography Scans in the Head Region. International
Journal of Radiation Oncology Biology Physics, 93(3):497–506. 21, 22
Erkla¨rung
Ich erkla¨re hiermit, dass ich die vorgelegte Dissertation selbst verfasst und mich dabei
keiner anderen, als der von mir ausdru¨cklich bezeichneten Quellen und Hilfen bedient
habe.
Heidelberg, den 16.09.2019
..........................................................................
